JP2011207871A - Liquid crystal compound, method for producing the same, liquid crystal composition and liquid crystal electrooptical element - Google Patents
Liquid crystal compound, method for producing the same, liquid crystal composition and liquid crystal electrooptical element Download PDFInfo
- Publication number
- JP2011207871A JP2011207871A JP2011051837A JP2011051837A JP2011207871A JP 2011207871 A JP2011207871 A JP 2011207871A JP 2011051837 A JP2011051837 A JP 2011051837A JP 2011051837 A JP2011051837 A JP 2011051837A JP 2011207871 A JP2011207871 A JP 2011207871A
- Authority
- JP
- Japan
- Prior art keywords
- group
- atom
- substituted
- liquid crystal
- cfcf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 142
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 121
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 14
- -1 naphthalene-2,6-diyl group Chemical group 0.000 claims abstract description 48
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims abstract description 25
- 125000005407 trans-1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])[C@]([H])([*:2])C([H])([H])C([H])([H])[C@@]1([H])[*:1] 0.000 claims abstract description 18
- 125000005657 1,3-cyclobutylene group Chemical group [H]C1([H])C([H])([*:1])C([H])([H])C1([H])[*:2] 0.000 claims abstract description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 52
- 125000001153 fluoro group Chemical group F* 0.000 claims description 39
- 229910052731 fluorine Inorganic materials 0.000 claims description 38
- 125000004432 carbon atom Chemical group C* 0.000 claims description 36
- 125000005843 halogen group Chemical group 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 125000003342 alkenyl group Chemical group 0.000 claims description 11
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 9
- 125000001931 aliphatic group Chemical group 0.000 claims description 8
- 125000002947 alkylene group Chemical group 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 8
- 229910052717 sulfur Inorganic materials 0.000 claims description 7
- 125000004434 sulfur atom Chemical group 0.000 claims description 7
- 239000011737 fluorine Substances 0.000 claims description 6
- 230000002140 halogenating effect Effects 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 150000001340 alkali metals Chemical group 0.000 claims description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 3
- 150000001342 alkaline earth metals Chemical group 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 13
- 125000005647 linker group Chemical group 0.000 abstract description 10
- 125000004093 cyano group Chemical group *C#N 0.000 description 46
- 239000002904 solvent Substances 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 10
- 239000010410 layer Substances 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 238000006467 substitution reaction Methods 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000004210 ether based solvent Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 125000000547 substituted alkyl group Chemical group 0.000 description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 210000002858 crystal cell Anatomy 0.000 description 4
- 238000013213 extrapolation Methods 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 3
- 125000003302 alkenyloxy group Chemical group 0.000 description 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 3
- 125000006350 alkyl thio alkyl group Chemical group 0.000 description 3
- 125000004414 alkyl thio group Chemical group 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 125000004991 fluoroalkenyl group Chemical group 0.000 description 3
- 125000004428 fluoroalkoxy group Chemical group 0.000 description 3
- 125000003709 fluoroalkyl group Chemical group 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 125000005017 substituted alkenyl group Chemical group 0.000 description 3
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- 125000005732 2,6-difluoro-1,4-phenylene group Chemical group [H]C1=C(F)C([*:1])=C(F)C([H])=C1[*:2] 0.000 description 2
- 125000005449 2-fluoro-1,4-phenylene group Chemical group [H]C1=C([*:2])C([H])=C(F)C([*:1])=C1[H] 0.000 description 2
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229910006404 SnO 2 Inorganic materials 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000005108 alkenylthio group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000004956 cyclohexylene group Chemical group 0.000 description 2
- 125000006575 electron-withdrawing group Chemical group 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 239000003566 sealing material Substances 0.000 description 2
- 125000005651 substituted 1,4-phenylene group Chemical group 0.000 description 2
- 125000005156 substituted alkylene group Chemical group 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- CXBDYQVECUFKRK-UHFFFAOYSA-N 1-methoxybutane Chemical compound CCCCOC CXBDYQVECUFKRK-UHFFFAOYSA-N 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 125000005450 2,3-difluoro-1,4-phenylene group Chemical group [H]C1=C([*:2])C(F)=C(F)C([*:1])=C1[H] 0.000 description 1
- 125000005714 2,5- (1,3-dioxanylene) group Chemical group [H]C1([H])OC([H])([*:1])OC([H])([H])C1([H])[*:2] 0.000 description 1
- 125000005728 2,5-pyrimidinylene group Chemical group [H]C1=NC([*:1])=NC([H])=C1[*:2] 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000005452 alkenyloxyalkyl group Chemical group 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 230000003098 cholesteric effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007697 cis-trans-isomerization reaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- VRLDVERQJMEPIF-UHFFFAOYSA-N dbdmh Chemical compound CC1(C)N(Br)C(=O)N(Br)C1=O VRLDVERQJMEPIF-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000011903 deuterated solvents Substances 0.000 description 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000006232 ethoxy propyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 125000006351 ethylthiomethyl group Chemical group [H]C([H])([H])C([H])([H])SC([H])([H])* 0.000 description 1
- 239000005262 ferroelectric liquid crystals (FLCs) Substances 0.000 description 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005446 heptyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000004372 methylthioethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])* 0.000 description 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
- 125000004373 methylthiopropyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005447 octyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001690 polydopamine Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000006233 propoxy propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])OC([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006225 propoxyethyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000005767 propoxymethyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])[#8]C([H])([H])* 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000000790 scattering method Methods 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal Substances (AREA)
Abstract
Description
本発明は、液晶化合物、その製造方法、該化合物を含有する液晶組成物および液晶表示素子に関する。 The present invention relates to a liquid crystal compound, a method for producing the same, a liquid crystal composition containing the compound, and a liquid crystal display device.
液晶素子は携帯電話やPDAのような携帯機器、複写機やパソコンモニタのようなOA機器用表示装置、液晶テレビなどの家電製品用表示装置をはじめ、時計、電卓、測定器、自動車用計器、カメラなどの用途に使用されており、広い動作温度範囲、低動作電圧、高速応答性、化学的安定性等の種々の性能が要求されている。
このような液晶素子には液晶相を示す材料が使用されているが、現在のところ、これら全ての特性を単独の化合物で満たすわけではなく、1つまたは2つ以上の特性の優れた複数の液晶化合物や非液晶性化合物を混合して液晶組成物として要求性能を満たしている。
液晶素子の分野において、液晶組成物に使用される化合物に要求される種々の特性の中でも、他の液晶材料または非液晶材料との相溶性に優れ、化学的にも安定であり、かつ液晶素子に用いた場合に広い温度範囲で高速応答性に優れ低電圧駆動できる性質を有する化合物または液晶組成物を提供することは重要な課題である。
Liquid crystal elements include mobile devices such as mobile phones and PDAs, display devices for office automation equipment such as copiers and personal computer monitors, display devices for home appliances such as liquid crystal televisions, clocks, calculators, measuring instruments, automotive meters, It is used for applications such as cameras, and various performances such as a wide operating temperature range, a low operating voltage, high-speed response, and chemical stability are required.
In such a liquid crystal element, a material exhibiting a liquid crystal phase is used, but at present, not all of these characteristics are satisfied by a single compound, and a plurality of excellent one or more characteristics are provided. Liquid crystal compounds and non-liquid crystal compounds are mixed to satisfy the required performance as a liquid crystal composition.
Among various properties required for compounds used in liquid crystal compositions in the field of liquid crystal elements, the liquid crystal elements have excellent compatibility with other liquid crystal materials or non-liquid crystal materials, are chemically stable, and are liquid crystal elements. It is an important problem to provide a compound or a liquid crystal composition having a property of being excellent in high-speed response in a wide temperature range and being capable of being driven at a low voltage.
このような課題の解決策として、これまでに、−CF=CF−や−CH=CF−などのフッ素原子で置換された不飽和連結基含有化合物や、−CF2O−連結基含有化合物が用いられてきている。(特許文献1、特許文献2、特許文献3)
しかし、不飽和連結基含有化合物は光に対する安定性に欠けるという問題点が有る。また、−CF2O−連結基含有化合物については、構造によっては−CF2O−が分解されてしまうことがあるという問題点がある。
As a solution to such problems, there have been unsaturated linking group-containing compounds substituted with fluorine atoms such as -CF = CF- and -CH = CF-, and -CF 2 O-linking group-containing compounds. It has been used. (Patent Document 1, Patent Document 2, Patent Document 3)
However, the unsaturated linking group-containing compound has a problem that it lacks stability to light. Further, the —CF 2 O— linking group-containing compound has a problem that —CF 2 O— may be decomposed depending on the structure.
本発明は、他の液晶材料または非液晶材料との相溶性に優れ、化学的にも安定である液晶化合物およびその製造方法を提供することを目的とする。また、該液晶化合物中の各基を調整することにより、前記の特性に加えて、大きな誘電率異方性等を併せ持つ液晶化合物を提供することも目的とする。
また、本発明は、該液晶化合物を含有し、広い温度範囲において低電圧で駆動でき、表示品位の高い液晶電気光学素子を得るのに好適な液晶組成物およびその液晶組成物を用いた液晶電気光学素子を提供することを目的とする。
An object of the present invention is to provide a liquid crystal compound that is excellent in compatibility with other liquid crystal materials or non-liquid crystal materials and is chemically stable, and a method for producing the same. Another object of the present invention is to provide a liquid crystal compound having a large dielectric anisotropy and the like in addition to the above characteristics by adjusting each group in the liquid crystal compound.
In addition, the present invention provides a liquid crystal composition suitable for obtaining a liquid crystal electro-optical element containing the liquid crystal compound and capable of being driven at a low voltage in a wide temperature range and having a high display quality, and a liquid crystal electrolysis using the liquid crystal composition. An object is to provide an optical element.
本発明者らは鋭意検討を重ねた結果、このような課題の解決策として、−CH=CFCF2O−連結基を有する特定構造の化合物を液晶組成物に含有させた場合に、その液晶組成物を用いた液晶電気光学素子が広い動作温度範囲、低動作電圧、高速応答性、化学的安定性等の種々の要求性能を満たすのに有用な化合物であることを見出し、本発明を完成させた。すなわち、本発明は、式(1)で表される液晶化合物を提供する。
R1−(A1)a−Z1−(A2)b−Z2−(A3)c−Z3−A4−CH=CFCF2O−A5−Z4−(A6)d−Z5−(A7)e−R2 (1)
式(1)中の記号は、以下の意味を示す。
R1、R2:相互に独立して、水素原子、ハロゲン原子、−CN、−NCS、−SF5または炭素数1〜18の1価の脂肪族炭化水素基であり、基中の1つ以上の−CH2 −は、エーテル性酸素原子(−O−)、チオエーテル性硫黄原子(−S−)で置換されていてもよく、基中の任意の水素原子はフッ素原子で置換されていてもよい。
A1、A2、A3、A4、A5、A6、A7:相互に独立して、トランス−1,4−シクロへキシレン基、1,4−シクロヘキセニレン基、1,3−シクロブチレン基、1,2−シクロプロピレン基、ナフタレン−2,6−ジイル基、1,2,3,4−テトラヒドロナフタレン−2,6−ジイル基、デカヒドロナフタレン−2,6−ジイル基、または1,4−フェニレン基。該基中の1つ以上の水素原子はハロゲン原子で置換されていてもよく、該基中に存在する1つまたは2つの=CH−基は窒素原子で置換されていてもよく、1つまたは2つの−CH2−基は−O−または−S−で置換されていてもよい。
Z1、Z2、Z3、Z4、Z5:相互に独立して、単結合、炭素数1〜4の2価の脂肪族炭化水素基であり、基中の1つ以上の−CH2 −は、−O−、−S−で置換されていてもよく、基中の任意の水素はフッ素で置換されていてもよい。
a、b、c、d、e:相互に独立して0または1。ただし、0≦a+b+c+d+e≦3。
As a result of intensive investigations, the present inventors have found that when a compound having a specific structure having a —CH═CFCF 2 O— linking group is contained in the liquid crystal composition, the liquid crystal composition thereof is solved as a solution to such a problem. We have found that liquid crystal electro-optic elements using materials are useful compounds that satisfy various performance requirements such as a wide operating temperature range, low operating voltage, high-speed response, and chemical stability. It was. That is, this invention provides the liquid crystal compound represented by Formula (1).
R 1 - (A 1) a -Z 1 - (A 2) b -Z 2 - (A 3) c -Z 3 -A 4 -CH = CFCF 2 O-A 5 -Z 4 - (A 6) d -Z 5 - (A 7) e -R 2 (1)
The symbol in Formula (1) shows the following meanings.
R 1 and R 2 are each independently a hydrogen atom, a halogen atom, —CN, —NCS, —SF 5 or a monovalent aliphatic hydrocarbon group having 1 to 18 carbon atoms, and one of the groups The above —CH 2 — may be substituted with an etheric oxygen atom (—O—) or a thioetheric sulfur atom (—S—), and any hydrogen atom in the group is substituted with a fluorine atom. Also good.
A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 : independently of each other, trans-1,4-cyclohexylene group, 1,4-cyclohexenylene group, 1, 3 -Cyclobutylene group, 1,2-cyclopropylene group, naphthalene-2,6-diyl group, 1,2,3,4-tetrahydronaphthalene-2,6-diyl group, decahydronaphthalene-2,6-diyl group Or 1,4-phenylene group. One or more hydrogen atoms in the group may be substituted with a halogen atom, and one or two ═CH— groups present in the group may be substituted with a nitrogen atom. Two —CH 2 — groups may be substituted with —O— or —S—.
Z 1 , Z 2 , Z 3 , Z 4 , Z 5 : each independently a single bond, a divalent aliphatic hydrocarbon group having 1 to 4 carbon atoms, and one or more —CH in the group 2 — may be substituted with —O— or —S—, and any hydrogen in the group may be substituted with fluorine.
a, b, c, d, e: 0 or 1 independently of each other. However, 0 ≦ a + b + c + d + e ≦ 3.
前記式(1)で表される液晶化合物のうちでも、下式(1−1)で表される化合物が好ましい。
R11−(A11)a−Z11−(A21)b−Z21−(A31)c−Z31−A41−CH=CFCF2O−A51−Z41−(A61)d−Z51−(A71)e−R21 (1−1)
式中の記号は、以下の意味を示す。
R11、R21:相互に独立して、水素原子、フッ素原子、−SF5、または炭素数1〜18のアルキル基、または炭素数2〜18のアルケニル基。該基中の1つ以上の−CH2−は−O−または−S−に置換されていてもよく、基中の1つ以上の水素原子はフッ素原子で置換されていてもよい。
A11、A21、A31、A41、A51、A61、A71:相互に独立して、トランス−1,4−シクロへキシレン基、または1,4−フェニレン基。該基中の1つ以上の水素原子はハロゲン原子で置換されていてもよく、基中に存在する1つまたは2つの=CH−基は窒素原子で置換されていてもよく、1つまたは2つの−CH2−基は−O−または−S−で置換されていてもよい。
Z11、Z21、Z31、Z41、Z51:相互に独立して、単結合、炭素数1〜4のアルキレン基であり、基中の1つ以上の−CH2−は−O−に置換されていてもよく、また基中の1つ以上の水素原子はフッ素原子で置換されていてもよい。
a、b、c、d、eは前記と同じ意味である。
Among the liquid crystal compounds represented by the formula (1), compounds represented by the following formula (1-1) are preferable.
R 11 - (A 11) a -Z 11 - (A 21) b -Z 21 - (A 31) c -Z 31 -A 41 -CH = CFCF 2 O-A 51 -Z 41 - (A 61) d -Z 51 - (A 71) e -R 21 (1-1)
The symbols in the formula have the following meanings.
R 11 and R 21 are each independently a hydrogen atom, a fluorine atom, —SF 5 , an alkyl group having 1 to 18 carbon atoms, or an alkenyl group having 2 to 18 carbon atoms. One or more —CH 2 — in the group may be substituted with —O— or —S—, and one or more hydrogen atoms in the group may be substituted with a fluorine atom.
A 11 , A 21 , A 31 , A 41 , A 51 , A 61 , A 71 : Independently of each other, a trans-1,4-cyclohexylene group or a 1,4-phenylene group. One or more hydrogen atoms in the group may be substituted with a halogen atom, and one or two ═CH— groups present in the group may be substituted with a nitrogen atom. One —CH 2 — group may be substituted with —O— or —S—.
Z 11 , Z 21 , Z 31 , Z 41 , Z 51 are each independently a single bond or an alkylene group having 1 to 4 carbon atoms, and one or more —CH 2 — in the group is —O—. In addition, one or more hydrogen atoms in the group may be substituted with a fluorine atom.
a, b, c, d and e have the same meaning as described above.
前記式(1)で表される液晶化合物のうちでも、下式(1−2)で表される化合物がより好ましい。
R12−(A12)a−Z12−(A22)b−Z22−(A32)c−Z32−A42−CH=CFCF2O−A52−Z42−(A62)d−Z52−(A72)e−R22 (1−2)
式中の記号は、以下の意味を示す。
R12:水素原子または炭素数1〜10のアルキル基。該基中の1つ以上の−CH2−は−O−で置換されていてもよく、また基中の1つ以上の水素原子はフッ素で置換されていてもよい。
R22:水素原子、フッ素原子、−SF5、または炭素数1〜10のアルキル基。該基中の1つ以上の−CH2−は−O−で置換されていてもよく、また基中の1つ以上の水素原子はフッ素原子で置換されていてもよい。
A12、A22、A32、A42、A52、A62、A72:相互に独立して、トランス−1,4−シクロへキシレン基、1,4−フェニレン基または1つもしくは2つのフッ素原子で置換された1,4−フェニレン基。
Z12、Z22、Z32、Z42、Z52:相互に独立して、単結合、炭素数1〜4のアルキレン基。
a、b、c、d、eは前記と同じ意味である。
Among the liquid crystal compounds represented by the formula (1), a compound represented by the following formula (1-2) is more preferable.
R 12 - (A 12) a -Z 12 - (A 22) b -Z 22 - (A 32) c -Z 32 -A 42 -CH = CFCF 2 O-A 52 -Z 42 - (A 62) d -Z 52 - (A 72) e -R 22 (1-2)
The symbols in the formula have the following meanings.
R 12 : a hydrogen atom or an alkyl group having 1 to 10 carbon atoms. One or more —CH 2 — in the group may be substituted with —O—, and one or more hydrogen atoms in the group may be substituted with fluorine.
R 22 : a hydrogen atom, a fluorine atom, —SF 5 , or an alkyl group having 1 to 10 carbon atoms. One or more —CH 2 — in the group may be substituted with —O—, and one or more hydrogen atoms in the group may be substituted with a fluorine atom.
A 12 , A 22 , A 32 , A 42 , A 52 , A 62 , A 72 : independently of each other, trans-1,4-cyclohexylene group, 1,4-phenylene group, or one or two of them 1,4-phenylene group substituted by a fluorine atom.
Z 12 , Z 22 , Z 32 , Z 42 , Z 52 : each independently a single bond, an alkylene group having 1 to 4 carbon atoms.
a, b, c, d and e have the same meaning as described above.
また、前記式(1)で表される液晶化合物の製造方法は、下記工程(1)および下記工程(2)を含むことが好ましい。
工程(1):下記式(2)で表される化合物をハロゲン化し下記式(3)で表される化合物を得る工程。
R1−(A1)a−Z1−(A2)b−Z2−(A3)c−Z3−A4−CH2CF=CF2 (2)
R1−(A1)a−Z1−(A2)b−Z2−(A3)c−Z3−A4−CH2CFX1CF2X2 (3)
工程(2):前記式(3)で表される化合物に対し、下記式(4)で表される化合物を反応させ、前記式(1)で表される液晶化合物を得る工程。
Y1O−A5−Z4−(A6)d−Z5−(A7)e−R2 (4)
式(2)、式(3)および式(4)中のR1、R2、A1、A2、A3、A4、A5、A6、A7、Z1、Z2、Z3、Z4、Z5、a、b、c、dおよびeは前記と同じ意味を示す。また、X1およびX2はハロゲン原子であり、Y1は水素原子、アルカリ金属原子、またはアルカリ土類金属原子である。
Moreover, it is preferable that the manufacturing method of the liquid crystal compound represented by said Formula (1) includes the following process (1) and the following process (2).
Step (1): A step of halogenating a compound represented by the following formula (2) to obtain a compound represented by the following formula (3).
R 1- (A 1 ) a -Z 1- (A 2 ) b -Z 2- (A 3 ) c -Z 3 -A 4 -CH 2 CF = CF 2 (2)
R 1 - (A 1) a -Z 1 - (A 2) b -Z 2 - (A 3) c -Z 3 -A 4 -CH 2 CFX 1 CF 2 X 2 (3)
Step (2): A step of obtaining a liquid crystal compound represented by the formula (1) by reacting a compound represented by the following formula (4) with the compound represented by the formula (3).
Y 1 O—A 5 —Z 4 — (A 6 ) d —Z 5 — (A 7 ) e —R 2 (4)
R 1 , R 2 , A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , Z 1 , Z 2 , Z in Formula (2), Formula (3) and Formula (4) 3 , Z 4 , Z 5 , a, b, c, d and e have the same meaning as described above. X 1 and X 2 are halogen atoms, and Y 1 is a hydrogen atom, an alkali metal atom, or an alkaline earth metal atom.
また、本発明は、前記式(3)で表される化合物を提供する。 The present invention also provides a compound represented by the formula (3).
また、本発明は、前記式(1)で表される液晶化合物(1)を含む液晶組成物を提供する。 The present invention also provides a liquid crystal composition comprising the liquid crystal compound (1) represented by the formula (1).
また、本発明は、該液晶組成物を、電極が配設された2枚の基板間に封入してなる液晶電気光学素子を提供する。 The present invention also provides a liquid crystal electro-optical element formed by sealing the liquid crystal composition between two substrates provided with electrodes.
本発明の式(1)で表される液晶化合物は、他の液晶材料または非液晶材料との相溶性に優れ、化学的にも安定である。また、本発明の化合物は、該化合物を構成する環基、置換基および連結基を適宜選択することにより、液晶素子に要求される様々な性能、具体的には、例えば、広い動作温度範囲、低動作電圧、高速応答性、化学的安定性等、を満たした液晶組成物を調製できる。かつ該液晶組成物を液晶電気光学素子に用いた場合に広い温度範囲で高速応答性に優れ低電圧駆動できる。
本発明の製造方法に従えば、−CH=CFCF2O−連結基を有する化合物を汎用性が高く工業的にも容易に簡便かつ効率的に製造することができる。
The liquid crystal compound represented by the formula (1) of the present invention is excellent in compatibility with other liquid crystal materials or non-liquid crystal materials, and is chemically stable. In addition, the compound of the present invention has various performances required for a liquid crystal element, specifically, for example, a wide operating temperature range, by appropriately selecting a ring group, a substituent and a linking group constituting the compound. A liquid crystal composition satisfying low operating voltage, high-speed response, chemical stability, etc. can be prepared. In addition, when the liquid crystal composition is used in a liquid crystal electro-optical element, it can be driven at a low voltage with excellent high-speed response in a wide temperature range.
According to the production method of the present invention, a compound having a —CH═CFCF 2 O— linking group is highly versatile and can be easily and efficiently produced easily and efficiently industrially.
以下に本発明について更に詳しく説明する。
本明細書において、式(1)で表される液晶化合物を化合物(1)と記し、他の式で表される化合物も同様に記す。
The present invention will be described in more detail below.
In this specification, the liquid crystal compound represented by the formula (1) is referred to as a compound (1), and the compounds represented by other formulas are also described in the same manner.
本発明の化合物(1)において、R1およびR2は、相互に独立して、水素原子、ハロゲン原子、−CN、−NCS、−SF5または炭素数1〜18の1価の脂肪族炭化水素基であり、該基中の1つ以上の−CH2 −は、−O−、−S−で置換されていてもよく、基中の任意の水素原子はフッ素原子で置換されていてもよく、これら基および水素原子の置換のいずれも含んでいてもよい。
以下、−O−、−S−およびフッ素原子の少なくとも1つによる置換を含むアルキル基を「置換アルキル基」と記す。
また、−O−、−S−およびフッ素原子の少なくとも1つによる置換を含むアルケニル基を「置換アルケニル基」と記す。
In the compound (1) of the present invention, R 1 and R 2 are each independently a hydrogen atom, a halogen atom, —CN, —NCS, —SF 5 or a monovalent aliphatic carbon atom having 1 to 18 carbon atoms. A hydrogen group, and one or more —CH 2 — in the group may be substituted with —O— or —S—, and any hydrogen atom in the group may be substituted with a fluorine atom. In addition, both of these groups and hydrogen atom substitution may be included.
Hereinafter, an alkyl group including substitution with at least one of —O—, —S— and a fluorine atom is referred to as a “substituted alkyl group”.
An alkenyl group containing a substitution with at least one of —O—, —S— and a fluorine atom is referred to as a “substituted alkenyl group”.
脂肪族炭化水素基としては、アルキル基、アルケニル基またはアルキニル基が挙げられ、中でもアルキル基またはアルケニル基が好ましい。
置換アルキル基としては、アルコキシ基、アルコキシアルキル基、アルキルチオ基、アルキルチオアルキル基、フルオロアルキル基、フルオロアルコキシ基等が挙げられる。
置換アルケニル基としては、アルケニルオキシ基、アルケニルオキシアルキル基、アルケニルチオ基、アルケニルチオアルキル基、フルオロアルケニル基、フルオロアルケニルオキシ基等が挙げられる。
Examples of the aliphatic hydrocarbon group include an alkyl group, an alkenyl group, and an alkynyl group, and among them, an alkyl group or an alkenyl group is preferable.
Examples of the substituted alkyl group include an alkoxy group, an alkoxyalkyl group, an alkylthio group, an alkylthioalkyl group, a fluoroalkyl group, and a fluoroalkoxy group.
Examples of the substituted alkenyl group include an alkenyloxy group, an alkenyloxyalkyl group, an alkenylthio group, an alkenylthioalkyl group, a fluoroalkenyl group, and a fluoroalkenyloxy group.
上記アルキル基としては、メチル基、エチル基、プロピル基、イソプロピル基、ブチル基、ペンチル基、ヘキシル基、ヘプチル基、オクチル基、ノニル基、デシル基等が挙げられる。
アルコキシ基としては、メトキシ基、エトキシ基、プロポキシ基、ブトキシ基、ペントキシ基、ヘプチルオキシ基、オクチルオキシ基等が挙げられる。
アルコキシアルキル基としては、メトキシメチル基、エトキシメチル基、プロポキシメチル基、プロポキシエチル基、メトキシプロピル基、エトキシプロピル基、プロポキシプロピル基等が挙げられる。
アルキルチオ基としては、メチルチオ基、エチルチオ基、プロピルチオ基、ブチルチオ基、ペンチルチオ基、ヘキシルチオ基、ヘプチルチオ基、オクチルチオ基等が挙げられる。
アルキルチオアルキル基としては、メチルチオメチル基、エチルチオメチル基、プロピルチオメチル基、ブチルチオメチル基、メチルチオエチル基、エチルチオエチル基、プロピルチオエチル基、メチルチオプロピル基、エチルチオプロピル基、プロピルチオプロピル基等が挙げられる。
アルケニル基としては、ビニル基、1−プロペニル基、1−ブテニル基、1−ペンテニル基、3−ブテニル基、3−ペンテニル基等が挙げられる。
アルケニルオキシ基としては、アリルオキシ基等が挙げられる。
フルオロアルキル基としては、トリフルオロメチル基、フルオロメチル基、2−フルオロエチル基、ジフルオロメチル基、2,2,2−トリフルオロエチル基、1,1,2,2−テトラフルオロエチル基、2−フルオロエチル基、3−フルオロプロピル基、4−フルオロブチル基、5−フルオロペンチル基等が挙げられる。
フルオロアルコキシ基としては、フルオロメトキシ基、トリフルオロメトキシ基、ジフルオロメトキシ基、ペンタフルオロエトキシ基、1,1,2,2−テトラフルオロエトキシ基、ヘプタフルオロプロポキシ基、1,1,2,3,3,3−ヘキサフルオロプロポキシ基等が挙げられる。
フルオロアルコキシアルキル基としては、トリフルオロメトキシメチル基等が挙げられる。
フルオロアルケニル基としては、2−フルオロエテニル基、2,2−ジフルオロエテニル基、1,2,2−トリフルオロエテニル基、3−フルオロ−1−ブテニル基、4−フルオロ−1−ブテニル基等が挙げられる。
フルオロアルキルチオ基としては、トリフルオロメチルチオ基、ジフルオロメチルチオ基、1,1,2,2−テトラフルオロエチルチオ基、2,2,2−トリフルオロエチルチオ基等が挙げられる。
Examples of the alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a nonyl group, and a decyl group.
Examples of the alkoxy group include a methoxy group, an ethoxy group, a propoxy group, a butoxy group, a pentoxy group, a heptyloxy group, and an octyloxy group.
Examples of the alkoxyalkyl group include a methoxymethyl group, an ethoxymethyl group, a propoxymethyl group, a propoxyethyl group, a methoxypropyl group, an ethoxypropyl group, and a propoxypropyl group.
Examples of the alkylthio group include a methylthio group, an ethylthio group, a propylthio group, a butylthio group, a pentylthio group, a hexylthio group, a heptylthio group, and an octylthio group.
Examples of alkylthioalkyl groups include methylthiomethyl, ethylthiomethyl, propylthiomethyl, butylthiomethyl, methylthioethyl, ethylthioethyl, propylthioethyl, methylthiopropyl, ethylthiopropyl, propylthio A propyl group etc. are mentioned.
Examples of the alkenyl group include a vinyl group, 1-propenyl group, 1-butenyl group, 1-pentenyl group, 3-butenyl group, and 3-pentenyl group.
Examples of the alkenyloxy group include an allyloxy group.
Fluoroalkyl groups include trifluoromethyl, fluoromethyl, 2-fluoroethyl, difluoromethyl, 2,2,2-trifluoroethyl, 1,1,2,2-tetrafluoroethyl, 2 -Fluoroethyl group, 3-fluoropropyl group, 4-fluorobutyl group, 5-fluoropentyl group and the like can be mentioned.
Fluoroalkoxy groups include fluoromethoxy group, trifluoromethoxy group, difluoromethoxy group, pentafluoroethoxy group, 1,1,2,2-tetrafluoroethoxy group, heptafluoropropoxy group, 1,1,2,3, Examples include 3,3-hexafluoropropoxy group.
Examples of the fluoroalkoxyalkyl group include a trifluoromethoxymethyl group.
As the fluoroalkenyl group, 2-fluoroethenyl group, 2,2-difluoroethenyl group, 1,2,2-trifluoroethenyl group, 3-fluoro-1-butenyl group, 4-fluoro-1-butenyl group Etc.
Examples of the fluoroalkylthio group include a trifluoromethylthio group, a difluoromethylthio group, a 1,1,2,2-tetrafluoroethylthio group, a 2,2,2-trifluoroethylthio group, and the like.
R1およびR2としては、水素原子、ハロゲン原子、−CN、−NCS、−SF5、アルキル基、アルケニル基、アルコキシ基、アルコキシアルキル基、アルキルチオ基、アルキルチオアルキル基、アルケニル基、アルケニルオキシ基、アルケニルチオ基、フルオロアルキル基、フルオロアルコキシ基、フルオロアルコキシアルキル基、フルオロアルケニル基、フルオロアルキルチオ基が好ましい。 R 1 and R 2 are hydrogen atom, halogen atom, —CN, —NCS, —SF 5 , alkyl group, alkenyl group, alkoxy group, alkoxyalkyl group, alkylthio group, alkylthioalkyl group, alkenyl group, alkenyloxy group. An alkenylthio group, a fluoroalkyl group, a fluoroalkoxy group, a fluoroalkoxyalkyl group, a fluoroalkenyl group, and a fluoroalkylthio group are preferred.
なかでも、R1およびR2としては、反応性や副反応が生じにくいことから、水素原子、フッ素原子、−SF5、炭素数1〜18のアルキル基、炭素数2〜18のアルケニル基、炭素数1〜18の置換アルキル基、炭素数2〜18の置換アルケニル基が好ましい。 Among these, as R 1 and R 2 , since reactivity and side reaction are unlikely to occur, a hydrogen atom, a fluorine atom, —SF 5 , an alkyl group having 1 to 18 carbon atoms, an alkenyl group having 2 to 18 carbon atoms, A substituted alkyl group having 1 to 18 carbon atoms and a substituted alkenyl group having 2 to 18 carbon atoms are preferable.
特に、R1としては、水素原子、炭素数1〜10のアルキル基または炭素数1〜10の置換アルキル基が特に好ましい。
R2としては、フッ素原子、−SF5、水素原子、炭素数1〜10のアルキル基または炭素数1〜10の置換アルキル基が特に好ましい。
In particular, R 1 is particularly preferably a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, or a substituted alkyl group having 1 to 10 carbon atoms.
R 2 is particularly preferably a fluorine atom, —SF 5 , a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, or a substituted alkyl group having 1 to 10 carbon atoms.
化合物(1)において、A1、A2、A3、A4、A5、A6およびA7は、相互に独立して、トランス−1,4−シクロへキシレン基、1,3−シクロブチレン基、1,2−シクロプロピレン基、ナフタレン−2,6−ジイル基、1,2,3,4−テトラヒドロナフタレン−2,6−ジイル基、デカヒドロナフタレン−2,6−ジイル基、または1,4−フェニレン基である。
これらA1〜A7各基中の1つ以上の水素原子はハロゲン原子で置換されていてもよく、またA1〜A7の各環を構成する=CH−基の1つまたは2つは窒素原子に置換されていてもよく、1つまたは2つの−CH2−基は−O−、−S−に置換されていてもよく、これら基および水素原子の置換のいずれも含んでいてもよい。このような置換を含む基を、各環基名の前に「置換」の語を付して、たとえば「置換1,4−フェニレン基」、「置換トランス−1、4−シクロヘキシレン基」などと称することがある。ここでのハロゲン原子としては、塩素原子およびフッ素原子が好ましい。
In the compound (1), A 1 , A 2 , A 3 , A 4 , A 5 , A 6 and A 7 are independently of each other a trans-1,4-cyclohexylene group, 1,3-cyclohexane. Butylene group, 1,2-cyclopropylene group, naphthalene-2,6-diyl group, 1,2,3,4-tetrahydronaphthalene-2,6-diyl group, decahydronaphthalene-2,6-diyl group, or 1,4-phenylene group.
One or more hydrogen atoms in each of these groups A 1 to A 7 may be substituted with a halogen atom, and one or two of the ═CH— groups constituting each ring of A 1 to A 7 are It may be substituted with a nitrogen atom, and one or two —CH 2 — groups may be substituted with —O— or —S—, and may contain any of these groups and hydrogen atoms. Good. For a group containing such a substitution, the term “substituted” is added to the front of each ring group name, for example, “substituted 1,4-phenylene group”, “substituted trans-1,4-cyclohexylene group”, etc. May be called. The halogen atom here is preferably a chlorine atom or a fluorine atom.
A1〜A7が1,4−フェニレン基であり、さらに置換基としてハロゲン原子を有する場合、1つの1,4−フェニレン基に置換するハロゲン原子の数は1つから4つであるが、中でも1つまたは2つが好ましい。トランス−1,4−シクロヘキシレン基であり、さらに置換基としてハロゲン原子を有する場合、置換するハロゲン原子の数は1〜4つであることが好ましい。また、ハロゲン原子はシクロヘキシレン基の1位または4位の炭素原子に結合していてもよい。
窒素原子による置換1,4−フェニレン基としては、2,5−ピリミジニレン基または2,5−ピリジニレン基等が挙げられる。
−O−、−S−による置換トランス−1,4−シクロへキシレン基としては、1,3−ジオキサン−2,5−ジイル基、1,3−ジチアン−2,5−ジイル基等が挙げられる。
In the case where A 1 to A 7 are 1,4-phenylene groups and further have a halogen atom as a substituent, the number of halogen atoms substituted on one 1,4-phenylene group is 1 to 4, Of these, one or two are preferred. When it is a trans-1,4-cyclohexylene group and further has a halogen atom as a substituent, the number of halogen atoms to be substituted is preferably 1 to 4. The halogen atom may be bonded to the 1st or 4th carbon atom of the cyclohexylene group.
Examples of the 1,4-phenylene group substituted with a nitrogen atom include 2,5-pyrimidinylene group and 2,5-pyridinylene group.
Examples of the substituted trans-1,4-cyclohexylene group by —O— or —S— include 1,3-dioxane-2,5-diyl group and 1,3-dithian-2,5-diyl group. It is done.
A1、A2、A3、A4、A5、A6およびA7としては、反応性や原料入手の関係から、トランス−1,4−シクロへキシレン基、1,4−フェニレン基、置換トランス−1,4−シクロへキシレン基、および置換1,4−フェニレン基が好ましい。
中でも、トランス−1,4−シクロへキシレン基、1,4−フェニレン基、および1つまたは2つのフッ素原子で置換された1,4−フェニレン基が特に好ましい。
As A 1 , A 2 , A 3 , A 4 , A 5 , A 6 and A 7 , trans-1,4-cyclohexylene group, 1,4-phenylene group, A substituted trans-1,4-cyclohexylene group and a substituted 1,4-phenylene group are preferred.
Among these, a trans-1,4-cyclohexylene group, a 1,4-phenylene group, and a 1,4-phenylene group substituted with one or two fluorine atoms are particularly preferable.
化合物(1)において、Z1、Z2、Z3、Z4およびZ5は、相互に独立して、単結合、炭素数1〜4の2価の脂肪族炭化水素基であり、該基中の1つ以上の−CH2−は、−O−または−S−で置換されていてもよく、基中の1つ以上の水素原子はフッ素原子で置換されていてもよく、これら基および水素原子の置換をいずれも含んでいてもよい。このような置換を有する基を、「置換」の語を付して称することがある。
置換アルキレン基としては、−CF2CF2−、−CF2CH2−、−CH2CF2−、−CHFCH2−、−CH2CHF−、−CF2CHF−、−CHFCF2−、−CH2O−、−OCH2−、−CH2S−、−SCH2−、−CF2O−、−OCF2−、−CF2CF2CF2CF2−、−OCF2CF2O−、−C2H4CF2O−、等が挙げられる。
また、Z1、Z2、Z3、Z4またはZ5が単結合である場合には、それぞれの基の両側に存在する基は直接結合することを意味する。例えば、Z1が単結合でありaおよびbが1の場合はA1とA2とは直接結合する。また、Z1、Z2およびZ3が単結合でありa、bおよびcが0である場合は、R1とA4とは直接結合する。
In the compound (1), Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are each independently a single bond, a divalent aliphatic hydrocarbon group having 1 to 4 carbon atoms, One or more —CH 2 — in the group may be substituted with —O— or —S—, and one or more hydrogen atoms in the group may be substituted with a fluorine atom. Any substitution of hydrogen atoms may be included. A group having such substitution may be referred to with the word “substitution”.
The substituted alkylene group, -CF 2 CF 2 -, - CF 2 CH 2 -, - CH 2 CF 2 -, - CHFCH 2 -, - CH 2 CHF -, - CF 2 CHF -, - CHFCF 2 -, - CH 2 O—, —OCH 2 —, —CH 2 S—, —SCH 2 —, —CF 2 O—, —OCF 2 —, —CF 2 CF 2 CF 2 CF 2 —, —OCF 2 CF 2 O— , -C 2 H 4 CF 2 O- , and the like.
Further, when Z 1 , Z 2 , Z 3 , Z 4 or Z 5 is a single bond, it means that groups existing on both sides of each group are directly bonded. For example, when Z 1 is a single bond and a and b are 1, A 1 and A 2 are directly bonded. When Z 1 , Z 2 and Z 3 are single bonds and a, b and c are 0, R 1 and A 4 are directly bonded.
Z1、Z2、Z3、Z4およびZ5としては、合成の容易さ等から、単結合、炭素数1〜4のアルキレン基、該基に対応するフッ素置換アルキレン基、または−O−置換アルキレン基が好ましい。
中でも、単結合および炭素数1〜4のアルキレン基が特に好ましい。
Z 1 , Z 2 , Z 3 , Z 4 and Z 5 are each a single bond, an alkylene group having 1 to 4 carbon atoms, a fluorine-substituted alkylene group corresponding to the group, or —O— for ease of synthesis or the like. A substituted alkylene group is preferred.
Among these, a single bond and an alkylene group having 1 to 4 carbon atoms are particularly preferable.
本発明の化合物(1)において、a、b、c、dおよびeは相互に独立して0または1である。
ただし、0≦a+b+c+d+e≦3である。
a、b、c、dおよびeは化合物に要求特性に応じて適宜選択することができる。
たとえば化合物(1)が低粘性であること、あるいは該化合物が他の液晶材料または非液晶材料との相溶性に優れている点を重視する場合、0≦a+b+c+d+e≦1であることが好ましい。一方、化合物の高い液晶温度範囲を重視する場合、1≦a+b+c+d+e≦3であることが好ましい。
In the compound (1) of the present invention, a, b, c, d and e are 0 or 1 independently of each other.
However, 0 ≦ a + b + c + d + e ≦ 3.
a, b, c, d and e can be appropriately selected according to the properties required of the compound.
For example, when importance is attached to the fact that the compound (1) has low viscosity or the compound is excellent in compatibility with other liquid crystal materials or non-liquid crystal materials, 0 ≦ a + b + c + d + e ≦ 1 is preferable. On the other hand, when emphasizing the high liquid crystal temperature range of the compound, it is preferable that 1 ≦ a + b + c + d + e ≦ 3.
化合物(1)のΔεを大きくする観点からは、−CH=CFCF2O−のO側結合基である、「−A5−Z4−(A6)d−Z5−(A7)e−R2」が、電子求引性の基であることが好ましいと考えられる。この「−A5−Z4−(A6)d−Z5−(A7)e−R2」の電子求引性とは、化合物(1)において、d=e=0かつZ4およびZ5が単結合である「−A5−R2」の、R2が水素原子かつA5が非置換のフェニレン基またはシクロヘキシレン基であるものに比して電子求引性であることを意味する。 From the viewpoint of increasing Δε of the compound (1), “—A 5 —Z 4 — (A 6 ) d —Z 5 — (A 7 ) e which is an O-side linking group of —CH═CFCF 2 O—. It is considered that —R 2 ”is preferably an electron withdrawing group. The electron withdrawing property of “−A 5 —Z 4 — (A 6 ) d —Z 5 — (A 7 ) e —R 2 ” means that in compound (1), d = e = 0, Z 4 and It is more electron withdrawing than “—A 5 —R 2 ” in which Z 5 is a single bond and R 2 is a hydrogen atom and A 5 is an unsubstituted phenylene group or cyclohexylene group. means.
「−A5−Z4−(A6)d−Z5−(A7)e−R2」が電子求引性の基となる場合としては、各基が以下のものであることが挙げられる。 In the case where “—A 5 —Z 4 — (A 6 ) d —Z 5 — (A 7 ) e —R 2 ” is an electron withdrawing group, it is mentioned that each group is as follows. It is done.
R2:フッ素原子、−OCF3、−OCF2H、−CN、−NCS、または−SF5
A5、A6、A7:相互に独立して、1,4−フェニレン基、2−フルオロ−1,4−フェニレン基、または2,6−ジフルオロ−1,4−フェニレン基。
Z4、Z5:単結合
d、e:相互に独立して0または1
また、A5、A6およびA7における置換型環基の置換位置は、R1に近いほうを4位、R2に近い方を1位とする。
R 2 : fluorine atom, —OCF 3 , —OCF 2 H, —CN, —NCS, or —SF 5
A 5 , A 6 , A 7 : independently of each other, a 1,4-phenylene group, a 2-fluoro-1,4-phenylene group, or a 2,6-difluoro-1,4-phenylene group.
Z 4 , Z 5 : single bond d, e: 0 or 1 independently of each other
The substitution positions of the substituted ring groups in A 5 , A 6 and A 7 are the 4th position closer to R 1 and the 1st position closer to R 2 .
従来より知られた−CF2O−連結基含有化合物において、−CF2O−の炭素原子側に1,4−フェニレン基が置換した場合、該基がフッ素原子で置換されていないと、−CF2O−連結基が不安定で加水分解により−COO−に変換してしまうことがある。
さらに、−CF=CF−などの不飽和連結基含有化合物においては、該連結基に1,4−フェニレン基が置換されている場合は、紫外光や可視光によりシス−トランスの異性化が生じ易いという問題が有る。
これに対して、本発明の−CH=CFCF2O−連結基を有する化合物においては、該連結基に、フッ素原子が置換されていない1,4−フェニレン基が置換されていても、連結基の分解や異性化がほとんど生じず、化合物の安定性が著しく向上するという特長を有すると考えられる。
このことから、本発明の−CH=CFCF2O−連結基を有する化合物は、連結基の両端の環基の構造をフッ素置換1,4−フェニレン基などに限定しなくても、化合物を安定して得ることができるという特長を有していることが期待される。
In a conventionally known —CF 2 O— linking group-containing compound, when a 1,4-phenylene group is substituted on the carbon atom side of —CF 2 O—, if the group is not substituted with a fluorine atom, The CF 2 O— linking group is unstable and may be converted to —COO— by hydrolysis.
Furthermore, in an unsaturated linking group-containing compound such as —CF═CF—, when a 1,4-phenylene group is substituted on the linking group, cis-trans isomerization occurs due to ultraviolet light or visible light. There is a problem that it is easy.
In contrast, in the compound having the —CH═CFCF 2 O— linking group of the present invention, the linking group may be substituted with a 1,4-phenylene group not substituted with a fluorine atom. The decomposition and isomerization hardly occur and the stability of the compound is remarkably improved.
Therefore, the compound having a —CH═CFCF 2 O— linking group of the present invention is stable even if the structure of the ring group at both ends of the linking group is not limited to a fluorine-substituted 1,4-phenylene group or the like. It is expected to have a feature that can be obtained.
本発明の化合物(1)としては、化合物(1−1)が好ましい。
R11−(A11)a−Z11−(A21)b−Z21−(A31)c−Z31−A41−CH=CFCF2O−A51−Z41−(A61)d−Z51−(A71)e−R21 (1−1)
式中の記号は、以下の意味を示す。
R11、R21:相互に独立して、水素原子、フッ素原子、−SF5、または炭素数1〜18のアルキル基、または炭素数2〜18のアルケニル基。該基中の1つ以上の−CH2−は−O−または−S−に置換されていてもよく、基中の1つ以上の水素原子はフッ素原子で置換されていてもよい。
A11、A21、A31、A41、A51、A61、A71:相互に独立して、トランス−1,4−シクロへキシレン基、または1,4−フェニレン基。該基中の1つ以上の水素原子はハロゲン原子で置換されていてもよく、基中に存在する1つまたは2つの=CH−基は窒素原子に置換されていてもよく、1つまたは2つの−CH2−基は−O−または−S−で置換されていてもよい。
Z11、Z21、Z31、Z41、Z51:相互に独立して、単結合、炭素数1〜4のアルキレン基であり、基中の1つ以上の−CH2−は−O−に置換されていてもよく、また基中の1つ以上の水素原子はフッ素原子で置換されていてもよい。
a、b、c、d、eは前記と同じ意味である。
As the compound (1) of the present invention, the compound (1-1) is preferable.
R 11 - (A 11) a -Z 11 - (A 21) b -Z 21 - (A 31) c -Z 31 -A 41 -CH = CFCF 2 O-A 51 -Z 41 - (A 61) d -Z 51 - (A 71) e -R 21 (1-1)
The symbols in the formula have the following meanings.
R 11 and R 21 are each independently a hydrogen atom, a fluorine atom, —SF 5 , an alkyl group having 1 to 18 carbon atoms, or an alkenyl group having 2 to 18 carbon atoms. One or more —CH 2 — in the group may be substituted with —O— or —S—, and one or more hydrogen atoms in the group may be substituted with a fluorine atom.
A 11 , A 21 , A 31 , A 41 , A 51 , A 61 , A 71 : Independently of each other, a trans-1,4-cyclohexylene group or a 1,4-phenylene group. One or more hydrogen atoms in the group may be substituted with a halogen atom, and one or two ═CH— groups present in the group may be substituted with a nitrogen atom. One —CH 2 — group may be substituted with —O— or —S—.
Z 11 , Z 21 , Z 31 , Z 41 , Z 51 are each independently a single bond or an alkylene group having 1 to 4 carbon atoms, and one or more —CH 2 — in the group is —O—. In addition, one or more hydrogen atoms in the group may be substituted with a fluorine atom.
a, b, c, d and e have the same meaning as described above.
本発明の化合物(1)としては、化合物(1−2)がより好ましい。
R12−(A12)a−Z12−(A22)b−Z22−(A32)c−Z32−A42−CH=CFCF2O−A52−Z42−(A62)d−Z52−(A72)e−R22 (1−2)
式中の記号は、以下の意味を示す。
R12:水素原子または炭素数1〜10のアルキル基。該基中の1つ以上の−CH2−は−O−に置換されていてもよく、また基中の1つ以上の水素原子はフッ素で置換されていてもよい。
R22:水素原子、フッ素原子、−SF5、または炭素数1〜10のアルキル基。該基中の1つ以上の−CH2−は−O−に置換されていてもよく、また基中の1つ以上の水素原子はフッ素で置換されていてもよい。
A12、A22、A32、A42、A52、A62、A72:相互に独立して、トランス−1,4−シクロへキシレン基、1,4−フェニレン基、1つまたは2つのフッ素原子で置換された1,4−フェニレン基。
Z12、Z22、Z32、Z42、Z52:相互に独立して、単結合、炭素数1〜4のアルキレン基。
a、b、c、d、eは前記と同じ意味である。
As the compound (1) of the present invention, the compound (1-2) is more preferable.
R 12 - (A 12) a -Z 12 - (A 22) b -Z 22 - (A 32) c -Z 32 -A 42 -CH = CFCF 2 O-A 52 -Z 42 - (A 62) d -Z 52 - (A 72) e -R 22 (1-2)
The symbols in the formula have the following meanings.
R 12 : a hydrogen atom or an alkyl group having 1 to 10 carbon atoms. One or more —CH 2 — in the group may be substituted with —O—, and one or more hydrogen atoms in the group may be substituted with fluorine.
R 22 : a hydrogen atom, a fluorine atom, —SF 5 , or an alkyl group having 1 to 10 carbon atoms. One or more —CH 2 — in the group may be substituted with —O—, and one or more hydrogen atoms in the group may be substituted with fluorine.
A 12 , A 22 , A 32 , A 42 , A 52 , A 62 , A 72 : independently of each other, trans-1,4-cyclohexylene group, 1,4-phenylene group, one or two 1,4-phenylene group substituted by a fluorine atom.
Z 12 , Z 22 , Z 32 , Z 42 , Z 52 : each independently a single bond, an alkylene group having 1 to 4 carbon atoms.
a, b, c, d and e have the same meaning as described above.
本発明の化合物(1)の製造方法には、化合物(2)にハロゲン原子を付加させ中間体である化合物(3)を得る工程(1)、および、得られた化合物(3)と化合物(4)とを反応させて化合物(1)を得る工程(2)が含まれることが好ましい。
工程(1):下記式(2)で表される化合物をハロゲン化し下記式(3)で表される化合物を得る工程。
R1−(A1)a−Z1−(A2)b−Z2−(A3)c−Z3−A4−CH2CF=CF2 (2)
R1−(A1)a−Z1−(A2)b−Z2−(A3)c−Z3−A4−CH2CFX1CF2X2 (3)
工程(2):前記式(3)で表される化合物に対し、下記式(4)で表される化合物を反応させ、前記式(1)で表される液晶化合物を得る工程。
Y1O−A5−Z4−(A6)d−Z5−(A7)e−R2 (4)
式(2)、式(3)および式(4)中のR1、R2、A1、A2、A3、A4、A5、A6、A7、Z1、Z2、Z3、Z4、Z5、a、b、c、dおよびeは前の定義および好ましい態様は前記化合物(1)と同じである。また、X1およびX2はハロゲン原子であり、Y1は水素原子、アルカリ金属原子、またはアルカリ土類金属原子である。
X1およびX2としては、反応性の面から臭素原子またはヨウ素原子が好ましい。
The production method of the compound (1) of the present invention includes the step (1) of obtaining a compound (3) as an intermediate by adding a halogen atom to the compound (2), and the obtained compound (3) and the compound ( It is preferable that the process (2) which obtains a compound (1) by making 4) react is included.
Step (1): A step of halogenating a compound represented by the following formula (2) to obtain a compound represented by the following formula (3).
R 1- (A 1 ) a -Z 1- (A 2 ) b -Z 2- (A 3 ) c -Z 3 -A 4 -CH 2 CF = CF 2 (2)
R 1 - (A 1) a -Z 1 - (A 2) b -Z 2 - (A 3) c -Z 3 -A 4 -CH 2 CFX 1 CF 2 X 2 (3)
Step (2): A step of obtaining a liquid crystal compound represented by the formula (1) by reacting a compound represented by the following formula (4) with the compound represented by the formula (3).
Y 1 O—A 5 —Z 4 — (A 6 ) d —Z 5 — (A 7 ) e —R 2 (4)
R 1 , R 2 , A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , Z 1 , Z 2 , Z in Formula (2), Formula (3) and Formula (4) 3 , Z 4 , Z 5 , a, b, c, d and e are the same as those in the above-mentioned compound (1) in the previous definition and preferred embodiments. X 1 and X 2 are halogen atoms, and Y 1 is a hydrogen atom, an alkali metal atom, or an alkaline earth metal atom.
X 1 and X 2 are preferably a bromine atom or an iodine atom from the viewpoint of reactivity.
本発明の出発物質である化合物(2)は、例えば、特開2008−19225号公報記載の方法で得る事ができる。 The compound (2) which is the starting material of the present invention can be obtained, for example, by the method described in JP-A-2008-19225.
化合物(2)をハロゲン化する試薬に制限はないが、塩素、臭素、ヨウ素、N−ブロモコハク酸イミド、N,N’-ジブロモ−5,5−ジメチルヒダントイン、N−ヨウドコハク酸イミドが好ましい。 The reagent for halogenating compound (2) is not limited, but chlorine, bromine, iodine, N-bromosuccinimide, N, N'-dibromo-5,5-dimethylhydantoin, and N-iodosuccinimide are preferable.
ハロゲン化試薬の使用量は化合物(2)1モルに対し、0.9〜5.0モルが好ましく、1〜2モルがより好ましい。 The amount of the halogenating reagent to be used is preferably 0.9 to 5.0 mol, more preferably 1 to 2 mol, per 1 mol of compound (2).
本発明の製造工程(1)は溶媒中で実施するのが好ましい。溶媒としてはベンゼン、トルエン、キシレン、エチルベンゼン等の芳香族炭化水素系溶媒、ペンタン、ヘキサン、ヘプタン、オクタン等の脂肪族炭化水素系溶媒;テトラヒドロフラン、ジエチルエーテル、ジイソプロピルエーテル、ジブチルエーテル、t−ブチルメチルエーテル、ジメトキシエタン等のエーテル系溶媒;塩化メチレン、1,2−ジクロロメタン、クロロホルム等のハロゲン系溶媒;石油エーテル類または前記溶媒の適当な混合溶媒等を用いることができる。これらの中でも、ジエチルエーテル、t−ブチルメチルエーテル等のエーテル系溶媒、ハロゲン系溶媒、エーテル系溶媒と脂肪族炭化水素系溶媒の混合溶媒が好ましい。 The production process (1) of the present invention is preferably carried out in a solvent. Solvents include aromatic hydrocarbon solvents such as benzene, toluene, xylene, and ethylbenzene, aliphatic hydrocarbon solvents such as pentane, hexane, heptane, and octane; tetrahydrofuran, diethyl ether, diisopropyl ether, dibutyl ether, and t-butylmethyl. Ether solvents such as ether and dimethoxyethane; halogen solvents such as methylene chloride, 1,2-dichloromethane and chloroform; petroleum ethers or a suitable mixed solvent of the above solvents can be used. Among these, ether solvents such as diethyl ether and t-butyl methyl ether, halogen solvents, ether solvents and aliphatic hydrocarbon solvents are preferable.
前記溶媒の量は、合成の規模により大きく異なり、適宜変更することが可能である。 The amount of the solvent varies greatly depending on the scale of synthesis, and can be changed as appropriate.
反応温度は−70〜50℃が好ましく、−10〜30℃がより好ましい。 The reaction temperature is preferably -70 to 50 ° C, more preferably -10 to 30 ° C.
反応時間は0.1〜24時間が好ましく、0.1〜3時間がより好ましい。 The reaction time is preferably 0.1 to 24 hours, more preferably 0.1 to 3 hours.
本製造方法は、化合物(2)が下記化合物(2−1)であり、化合物(3)が下記化合物(3−1)である場合が好ましい。
R11−(A11)a−Z11−(A21)b−Z21−(A31)c−Z31−A41−CH2CF=CF2 (2−1)
R11−(A11)a−Z11−(A21)b−Z21−(A31)c−Z31−A41−CH2CFX11CF2X21 (3−1)
式中のX11およびX21は臭素原子またはヨウ素原子であり、各式中の記号は前記と同じ意味を示す。
In this production method, the compound (2) is preferably the following compound (2-1), and the compound (3) is preferably the following compound (3-1).
R 11 - (A 11) a -Z 11 - (A 21) b -Z 21 - (A 31) c -Z 31 -A 41 -CH 2 CF = CF 2 (2-1)
R 11 - (A 11) a -Z 11 - (A 21) b -Z 21 - (A 31) c -Z 31 -A 41 -CH 2 CFX 11 CF 2 X 21 (3-1)
X 11 and X 21 in the formula are a bromine atom or an iodine atom, and the symbols in each formula have the same meaning as described above.
また、本発明の製造方法は、化合物(2)が下記化合物(2−2)であり、化合物(3)が下記化合物(3−2)である場合が特に好ましい。
R12−(A12)a−Z12−(A22)b−Z22−(A32)c−Z32−A42−CH2CF=CF2 (2−2)
R12−(A12)a−Z12−(A22)b−Z22−(A32)c−Z32−A42−CH2CFX11CF2X21 (3−2)
各式中の記号は前記と同じ意味を示す。
In the production method of the present invention, it is particularly preferable that the compound (2) is the following compound (2-2) and the compound (3) is the following compound (3-2).
R 12 - (A 12) a -Z 12 - (A 22) b -Z 22 - (A 32) c -Z 32 -A 42 -CH 2 CF = CF 2 (2-2)
R 12 - (A 12) a -Z 12 - (A 22) b -Z 22 - (A 32) c -Z 32 -A 42 -CH 2 CFX 11 CF 2 X 21 (3-2)
The symbols in each formula have the same meaning as described above.
化合物(4)は、市販品あるいは新実験化学講座(丸善株式会社出版)等、有機合成の成書に記載されている方法にて容易に得られる。 The compound (4) can be easily obtained by a method described in an organic synthesis book such as a commercially available product or a new experimental chemical course (published by Maruzen Co., Ltd.).
化合物(4)の使用量は化合物(3)1モルに対し、0.9〜5.0モルが好ましく、1〜2モルがより好ましい。 0.9-5.0 mol is preferable with respect to 1 mol of compound (3), and, as for the usage-amount of a compound (4), 1-2 mol is more preferable.
本発明の工程(2)は塩基を用いて実施するのが好ましい。塩基としては、アルカリ金属の水酸化物、水素化物、アルキル化物、アルコキサイド、アミドまたは炭酸塩が挙げられる。この他に、アミンを用いることができる。 Step (2) of the present invention is preferably carried out using a base. Bases include alkali metal hydroxides, hydrides, alkylates, alkoxides, amides or carbonates. In addition, an amine can be used.
本発明の工程(2)は溶媒中で実施するのが好ましい。溶媒としては水や、ベンゼン、トルエン、キシレン、エチルベンゼン等の芳香族炭化水素系溶媒、ペンタン、ヘキサン、ヘプタン、オクタン等の脂肪族炭化水素系溶媒;テトラヒドロフラン、ジエチルエーテル、ジイソプロピルエーテル、ジブチルエーテル、t−ブチルメチルエーテル、ジメトキシエタン等のエーテル系溶媒;N,N−ジメチルホルムアミド(DMF)、ジメチルスルホキシド(DMSO)等の非プロトン性極性溶媒;石油エーテル類または前記溶媒の適当な混合溶媒等を用いることができる。これらの中でも、ジエチルエーテル、t−ブチルメチルエーテル等のエーテル系溶媒、DMF、DMSO等の非プロトン性極性溶媒、エーテル系溶媒と脂肪族炭化水素系溶媒の混合溶媒、水と脂肪族炭化水素系溶媒の混合溶媒が好ましい。 The step (2) of the present invention is preferably carried out in a solvent. Solvents include water, aromatic hydrocarbon solvents such as benzene, toluene, xylene, and ethylbenzene, aliphatic hydrocarbon solvents such as pentane, hexane, heptane, and octane; tetrahydrofuran, diethyl ether, diisopropyl ether, dibutyl ether, t -Ether solvents such as butyl methyl ether and dimethoxyethane; aprotic polar solvents such as N, N-dimethylformamide (DMF) and dimethyl sulfoxide (DMSO); petroleum ethers or a suitable mixed solvent of the above solvents be able to. Among these, ether solvents such as diethyl ether and t-butyl methyl ether, aprotic polar solvents such as DMF and DMSO, mixed solvents of ether solvents and aliphatic hydrocarbon solvents, water and aliphatic hydrocarbon systems A mixed solvent of solvents is preferred.
前記溶媒の量は、合成の規模により大きく異なり、適宜変更することが可能である。 The amount of the solvent varies greatly depending on the scale of synthesis, and can be changed as appropriate.
反応温度は−70〜200℃が好ましく、−10〜130℃がより好ましい。 The reaction temperature is preferably -70 to 200 ° C, more preferably -10 to 130 ° C.
反応時間は0.1〜24時間が好ましく、1〜3時間がより好ましい。 The reaction time is preferably 0.1 to 24 hours, more preferably 1 to 3 hours.
本発明の製造方法において、化合物(3)が下記化合物(3−1)であり、化合物(4)が下記化合物(4−1)である場合が好ましい。
R11−(A11)a−Z11−(A21)b−Z21−(A31)c−Z31−A41−CH2CFX1CF2X2(3−1)
Y1O−A51−Z41−(A61)d−Z51−(A71)e−R21 (4−1)
各式中の記号は前記と同じ意味を示す。
In the manufacturing method of this invention, the case where a compound (3) is the following compound (3-1) and a compound (4) is the following compound (4-1) is preferable.
R 11 - (A 11) a -Z 11 - (A 21) b -Z 21 - (A 31) c -Z 31 -A 41 -CH 2 CFX 1 CF 2 X 2 (3-1)
Y 1 O-A 51 -Z 41 - (A 61) d -Z 51 - (A 71) e -R 21 (4-1)
The symbols in each formula have the same meaning as described above.
また、本発明の製造方法において、化合物(3)が下記化合物(3−2)であり、化合物(4)が下記化合物(4−2)である場合が特に好ましい。
R12−(A12)a−Z12−(A22)b−Z22−(A32)c−Z32−A42−CH2CFX1CF2X2(3−2)
Y1O−A52−Z42−(A62)d−Z52−(A72)e−R22 (4−2)
各式中の記号は前記と同じ意味を示す。
Moreover, in the manufacturing method of this invention, the case where a compound (3) is the following compound (3-2) and a compound (4) is the following compound (4-2) is especially preferable.
R 12 - (A 12) a -Z 12 - (A 22) b -Z 22 - (A 32) c -Z 32 -A 42 -CH 2 CFX 1 CF 2 X 2 (3-2)
Y 1 O—A 52 —Z 42 — (A 62 ) d —Z 52 — (A 72 ) e —R 22 (4-2)
The symbols in each formula have the same meaning as described above.
また、本発明は、前記化合物(1)を含む液晶組成物を提供する。この液晶組成物は、本発明の化合物(1)と、他の液晶化合物または非液晶化合物(これらを総称して「他の化合物」という)とを混合して構成される。 The present invention also provides a liquid crystal composition comprising the compound (1). This liquid crystal composition is constituted by mixing the compound (1) of the present invention with other liquid crystal compounds or non-liquid crystal compounds (collectively referred to as “other compounds”).
本発明の液晶組成物における化合物(1)の含有量は、用途、使用目的、他の化合物の種類等により適宜変更することができるが、液晶組成物全量に対して化合物(1)は0.5〜50質量%が好ましく、特に2〜20質量%が好ましい。また、用途、使用目的等により、液晶組成物中に化合物(1)を2種類以上含有してもよい。その場合、液晶組成物の全量に対して化合物(1)の合計量で0.5〜80質量%が好ましく、特に2〜50質量%が好ましい。 The content of the compound (1) in the liquid crystal composition of the present invention can be appropriately changed depending on the purpose of use, the purpose of use, the type of other compounds, and the like. 5-50 mass% is preferable, and 2-20 mass% is especially preferable. Moreover, you may contain 2 or more types of compounds (1) in a liquid-crystal composition by a use, a use purpose, etc. In that case, 0.5-80 mass% is preferable with the total amount of a compound (1) with respect to the whole quantity of a liquid-crystal composition, and 2-50 mass% is especially preferable.
化合物(1)と混合して用いる他の化合物としては、屈折率異方性値を調整する成分、粘性を下げる成分、低温で液晶性を示す成分、誘電率異方性を向上させる成分、コレステリック性を付与する成分、二色性を示す成分、導電性を付与する成分、その他各種添加剤等が挙げられる。これらは、用途、要求性能等により、適宜選択されるが、通常は、液晶化合物および該液晶化合物と類似構造を有する主成分と、必要に応じて添加される添加成分とからなるものが好ましい。 Other compounds used in combination with the compound (1) include components for adjusting the refractive index anisotropy value, components for reducing the viscosity, components exhibiting liquid crystallinity at low temperatures, components for improving the dielectric anisotropy, and cholesteric A component for imparting properties, a component exhibiting dichroism, a component for imparting conductivity, and various other additives. These are appropriately selected depending on the application, required performance and the like, but usually those composed of a liquid crystal compound, a main component having a similar structure to the liquid crystal compound, and an additive component added if necessary.
本発明の液晶組成物において、前記他の化合物としては、例えば、以下の式で表されるものが挙げられる。以下の式中、R3およびR4は、アルキル基、アルケニル基、アルキニル基、アルコキシ基、ハロゲン原子またはシアノ基等の基を表す。また、R3およびR4は、それぞれ同一であっても異なっていてもよい。
以下の各式中、−Cy−はトランス−1,4−シクロへキシレン基を表し、−Ph−は1,4−フェニレン基を表し、−PhFF−はジフロオロフェニレン基を表す。
In the liquid crystal composition of the present invention, examples of the other compound include those represented by the following formulae. In the following formulae, R 3 and R 4 represent a group such as an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, a halogen atom or a cyano group. R 3 and R 4 may be the same or different from each other.
In the following formulas, -Cy- represents a trans-1,4-cyclohexylene group, -Ph- represents a 1,4-phenylene group, and -PhFF- represents a difluorophenylene group.
R3−Cy−Cy−R4
R3−Cy−Ph−R4
R3−Cy−PhFF−CN
R3−Ph−Ph−R4
R3−Ph−C≡C−Ph−R4
R3−Cy−COO−Ph−R4
R3−Cy−COO−PhFF−CN
R3−Ph−COO−Ph−R4
R3−Ph−COO−PhFF−CN
R3−Cy−CH=CH−Ph−R4
R3−Ph−CH=CH−Ph−R4
R3−Ph−CF=CF−Ph−R4
R3−Cy−CF=CF−Ph−R4
R3−Cy−CF=CF−Cy−R4
R3−Cy−Ph−CF=CF−Ph−R4
R3−Cy−Ph−CF=CF−Cy−R4
R 3 -Cy-Cy-R 4
R 3 -Cy-Ph-R 4
R 3 -Cy-PhFF-CN
R 3 -Ph-Ph-R 4
R 3 —Ph—C≡C—Ph—R 4
R 3 -Cy-COO-Ph-R 4
R 3 -Cy-COO-PhFF- CN
R 3 —Ph—COO—Ph—R 4
R 3 -Ph-COO-PhFF-CN
R 3 —Cy—CH═CH—Ph—R 4
R 3 —Ph—CH═CH—Ph—R 4
R 3 —Ph—CF═CF—Ph—R 4
R 3 —Cy—CF═CF—Ph—R 4
R 3 —Cy—CF═CF—Cy—R 4
R 3 —Cy—Ph—CF═CF—Ph—R 4
R 3 —Cy—Ph—CF═CF—Cy—R 4
R3−Ph−Cy−CF=CF−Cy−R4
R3−Cy−Cy−CF=CF−Ph−R4
R3−Ph−Ph−CF=CF−Ph−R4
R3−Cy−CH2 CH2 −Ph−R4
R3−Cy−Ph−CH2 CH2−Ph−R4
R3−Cy−Ph−CH2 CH2−Cy−R4
R3−Cy−Cy−CH2 CH2−Ph−R4
R3−Ph−CH2 CH2−Ph−R4
R3−Ph−Ph−CH2 CH2−Ph−R4
R3−Ph−Ph−CH2 CH2−Cy−R4
R3−Cy−Ph−Ph−R4
R3−Cy−Ph−PhFF−CN
R3−Cy−Ph−C≡C−Ph−R4
R3−Cy−Ph−C≡C−PhFF−CN
R3−Cy−Ph−C≡C−Ph−Cy−R4
R3−Cy−CH2 CH2−Ph−C≡C−Ph−R4
R 3 —Ph—Cy—CF═CF—Cy—R 4
R 3 —Cy—Cy—CF═CF—Ph—R 4
R 3 —Ph—Ph—CF═CF—Ph—R 4
R 3 -Cy-CH 2 CH 2 -Ph-R 4
R 3 -Cy-Ph-CH 2 CH 2 -Ph-R 4
R 3 -Cy-Ph-CH 2 CH 2 -Cy-R 4
R 3 -Cy-Cy-CH 2 CH 2 -Ph-R 4
R 3 -Ph-CH 2 CH 2 -Ph-R 4
R 3 -Ph-Ph-CH 2 CH 2 -Ph-R 4
R 3 -Ph-Ph-CH 2 CH 2 -Cy-R 4
R 3 -Cy-Ph-Ph-R 4
R 3 -Cy-Ph-PhFF-CN
R 3 -Cy-Ph-C≡C-Ph-R 4
R 3 -Cy-Ph-C≡C-PhFF-CN
R 3 -Cy-Ph-C≡C-Ph-Cy-R 4
R 3 —Cy—CH 2 CH 2 —Ph—C≡C—Ph—R 4
R3−Cy−CH2 CH2−Ph−C≡C−Ph−Cy−R4
R3−Cy−Ph−Ph−Cy−R4
R3−Ph−Ph−Ph−R4
R3−Ph−Ph−C≡C−Ph−R4
R3−Ph−CH2 CH2−Ph−C≡C−Ph−R4
R3−Ph−CH2 CH2−Ph−C≡C−Ph−Cy−R4
R3−Cy−COO−Ph−Ph−R4
R3−Cy−COO−Ph−PhFF−CN
R3−Cy−Ph−COO−Ph−R4
R3−Cy−Ph−COO−PhFF−CN
R3−Cy−COO−Ph−COO−Ph−R
R3−Cy−COO−Ph−COO−PhFF−CN
R3−Ph−COO−Ph−COO−Ph−R4
R3−Ph−COO−Ph−OCO−Ph−R4
R3−Ph−CF2 O−Ph−R4
R 3 —Cy—CH 2 CH 2 —Ph—C≡C—Ph—Cy—R 4
R 3 -Cy-Ph-Ph-Cy-R 4
R 3 -Ph-Ph-Ph-R 4
R 3 —Ph—Ph—C≡C—Ph—R 4
R 3 —Ph—CH 2 CH 2 —Ph—C≡C—Ph—R 4
R 3 —Ph—CH 2 CH 2 —Ph—C≡C—Ph—Cy—R 4
R 3 -Cy-COO-Ph- Ph-R 4
R 3 -Cy-COO-Ph- PhFF-CN
R 3 -Cy-Ph-COO- Ph-R 4
R 3 -Cy-Ph-COO- PhFF-CN
R 3 -Cy-COO-Ph- COO-Ph-R
R 3 -Cy-COO-Ph- COO-PhFF-CN
R 3 -Ph-COO-Ph- COO-Ph-R 4
R 3 -Ph-COO-Ph- OCO-Ph-R 4
R 3 —Ph—CF 2 O—Ph—R 4
R3−Cy−CF2 O−Ph−R4
R3−Ph−CF2 O−Cy−R4
R3−Cy−Ph−CF2 O−Ph−R4
R3−Cy−Ph−CF2 O−Cy−R4
R3−Cy−Cy−CF2 O−Ph−R4
R3−Ph−Ph−CF2 O−Ph−R4
R3−Ph−Ph−CF2 O−Cy−R4
R3−Cy−Ph−CF2 O−PhFF−R4
R3−Cy−PhFF−CF2 O−PhFF−R4
R3−Ph−Ph−CF2 O−PhFF−R4
R3−Ph−PhFF−CF2 O−PhFF−R4
R3−Ph−CF2 CF2 −Ph−R4
R 3 —Cy—CF 2 O—Ph—R 4
R 3 —Ph—CF 2 O—Cy—R 4
R 3 -Cy-Ph-CF 2 O-Ph-R 4
R 3 -Cy-Ph-CF 2 O-Cy-R 4
R 3 -Cy-Cy-CF 2 O-Ph-R 4
R 3 -Ph-Ph-CF 2 O-Ph-R 4
R 3 -Ph-Ph-CF 2 O-Cy-R 4
R 3 -Cy-Ph-CF 2 O-PhFF-R 4
R 3 -Cy-PhFF-CF 2 O-PhFF-R 4
R 3 -Ph-Ph-CF 2 O-PhFF-R 4
R 3 -Ph-PhFF-CF 2 O-PhFF-R 4
R 3 -Ph-CF 2 CF 2 -Ph-R 4
R3−Cy−CF2 CF2−Ph−R4
R3−Cy−CF2 CF2−Cy−R4
R3−Cy−Ph−CF2 CF2−Ph−R4
R3−Cy−Ph−CF2 CF2−Cy−R4
R3−Cy−Cy−CF2 CF2−Ph−R4
R3−Ph−Ph−CF2 CF2−Ph−R4
R3−Ph−Ph−CF2 CF2−Cy−R4
R 3 -Cy-CF 2 CF 2 -Ph-R 4
R 3 —Cy—CF 2 CF 2 —Cy—R 4
R 3 -Cy-Ph-CF 2 CF 2 -Ph-R 4
R 3 -Cy-Ph-CF 2 CF 2 -Cy-R 4
R 3 -Cy-Cy-CF 2 CF 2 -Ph-R 4
R 3 -Ph-Ph-CF 2 CF 2 -Ph-R 4
R 3 -Ph-Ph-CF 2 CF 2 -Cy-R 4
なお、これらの化合物は単なる代表例であり、該化合物中の環構造または末端基に存在する水素原子が、ハロゲン原子、シアノ基、メチル基等に置換されたものでもよい。また、シクロヘキサン環やベンゼン環が他の六員環や五員環、例えば、ピリミジン環やジオキサン環等に置換されたものでもよく、環と環との間の結合基がそれぞれ独立して他の2価の結合基、例えば−CH2 O−、−CH=CH−、−N=N−、−CH=N−、−COOCH2 −、−OCOCH2 −または−COCH2 −等に変更されているものでもよく、所望の性能に合わせて選択することができる。 These compounds are merely representative examples, and a hydrogen atom present in a ring structure or a terminal group in the compound may be substituted with a halogen atom, a cyano group, a methyl group, or the like. In addition, the cyclohexane ring or the benzene ring may be substituted with another 6-membered ring or 5-membered ring, for example, a pyrimidine ring or a dioxane ring. Changed to a divalent linking group such as —CH 2 O—, —CH═CH—, —N═N—, —CH═N—, —COOCH 2 —, —OCOCH 2 — or —COCH 2 —, etc. It can be selected according to the desired performance.
さらに、本発明は、前記液晶組成物を液晶層の構成材として用いる液晶電気光学素子を提供する。本明細書において、液晶電気光学素子とは、表示素子に限られず、液晶の電気的または光学的特性を利用する各種の機能素子、例えば、液晶表示素子、さらに、調光窓、光シャッター、偏光変換素子、可変焦点レンズ等の用途に用いられる素子を含むものである。例えば、本発明の液晶組成物を液晶セル内に注入する等して形成される液晶層を、電極を備える2枚の基板間に挟持して構成される電気光学素子部を有する液晶電気光学素子を提供する。この液晶電気光学素子は、ツイストネマチック(TN)方式、スーパーツイストネマチック(STN)方式、ECBモード、VAモード、ゲストホスト方式、動的散乱方式、フェーズチェンジ方式、DAP方式、二周波駆動方式、強誘電性液晶表示方式等種々のモードで駆動されるものが挙げられる。 Furthermore, the present invention provides a liquid crystal electro-optical element that uses the liquid crystal composition as a constituent material of a liquid crystal layer. In this specification, the liquid crystal electro-optical element is not limited to a display element, but various functional elements that use the electrical or optical characteristics of liquid crystal, for example, a liquid crystal display element, a light control window, an optical shutter, and a polarization It includes elements used for applications such as conversion elements and variable focus lenses. For example, a liquid crystal electro-optical element having an electro-optical element portion formed by sandwiching a liquid crystal layer formed by, for example, injecting the liquid crystal composition of the present invention into a liquid crystal cell between two substrates having electrodes. I will provide a. This liquid crystal electro-optic element is a twisted nematic (TN) method, a super twisted nematic (STN) method, an ECB mode, a VA mode, a guest host method, a dynamic scattering method, a phase change method, a DAP method, a dual frequency drive method, a strong Examples include those driven in various modes such as a dielectric liquid crystal display system.
代表的な液晶電気光学素子としては、ツイストネマチック(TN)型液晶表示素子が挙げられる。このツイストネマチック(TN)型液晶表示素子は、まず、プラスチック、ガラス等の基板上に、必要に応じてSiO2 、Al2 O3 等のアンダーコート層やカラーフィルター層を形成し、In2 O3 −SnO2 (ITO)、SnO2 等からなる被膜を成膜し、ホトリソグラフィ等により所要のパターンの電極を形成する。次に、必要に応じて、ポリイミド、ポリアミド、SiO2 、Al2 O3 等のオーバーコート層を形成し、配向処理する。これにシール材を印刷し、電極面が相対向するように配して周辺をシールし、シール材を硬化して空セルを形成する。 A typical liquid crystal electro-optic element includes a twisted nematic (TN) type liquid crystal display element. The twisted nematic (TN) type liquid crystal display device, first, plastics, onto a substrate such as glass, of SiO 2, Al 2 O undercoat layer or a color filter layer, such as 3 to form optionally, an In 2 O A film made of 3- SnO 2 (ITO), SnO 2 or the like is formed, and an electrode having a required pattern is formed by photolithography or the like. Next, if necessary, an overcoat layer of polyimide, polyamide, SiO 2 , Al 2 O 3 or the like is formed and oriented. A sealing material is printed on this, it arrange | positions so that an electrode surface may mutually oppose, a periphery is sealed, a sealing material is hardened, and an empty cell is formed.
さらに、空セルに、本発明の組成物を注入し、注入口を封止剤で封止して液晶セルを構成する。この液晶セルに、必要に応じて、偏光板、カラー偏光板、光源、カラーフィルター、半透過反射板、反射板、導光板、紫外線カットフィルター等を積層、文字、図形等を印刷、ノングレア加工等をして液晶電気光学素子を得ることができる。 Furthermore, the composition of the present invention is injected into an empty cell, and the injection port is sealed with a sealant to form a liquid crystal cell. If necessary, this liquid crystal cell is laminated with a polarizing plate, a color polarizing plate, a light source, a color filter, a transflective plate, a reflecting plate, a light guide plate, an ultraviolet cut filter, etc., printing characters, figures, etc., non-glare processing, etc. Thus, a liquid crystal electro-optical element can be obtained.
なお、上述の説明は、液晶電気光学素子の基本的な構成および製法を説明したものであり、他の構成も採用できる。例えば、2層電極を用いた基板、2層の液晶層を形成した2層液晶セル、反射電極を用いた基板、TFT、MIM等の能動素子を形成したアクティブマトリクス基板を用いたアクティブマトリクス素子等、種々の構成のものが採用できる。 Note that the above description describes the basic configuration and manufacturing method of the liquid crystal electro-optical element, and other configurations can be employed. For example, a substrate using a two-layer electrode, a two-layer liquid crystal cell having a two-layer liquid crystal layer, a substrate using a reflective electrode, an active matrix device using an active matrix substrate having an active element such as a TFT or MIM, etc. Various configurations can be employed.
さらに、本発明の組成物は、前記TN型以外のモード、即ち、高ツイスト角のSTN型液晶電気光学素子や、多色性色素を用いたゲスト−ホスト(GH)型液晶電気光学素子、横方向の電界で液晶分子を基板に対して平行に駆動させるインプレーンスイッチング(IPS)型液晶電気光学素子、液晶分子を基板に対して垂直配向させるVA型液晶電気光学素子、強誘電性液晶電気光学素子等、種々の方式で使用することができる。また、電気的に書き込みをする方式ではなく、熱により書き込みをする方式に用いることもできる。 Furthermore, the composition of the present invention is a mode other than the TN type, that is, a high twist angle STN type liquid crystal electro-optical element, a guest-host (GH) type liquid crystal electro-optical element using a pleochroic dye, In-plane switching (IPS) type liquid crystal electro-optical element that drives liquid crystal molecules parallel to the substrate by a direction electric field, VA type liquid crystal electro-optical element that aligns liquid crystal molecules vertically with respect to the substrate, ferroelectric liquid crystal electro-optics It can be used in various ways such as an element. Further, it can be used not only in a method of electrically writing but also in a method of writing by heat.
以下に、実施例を挙げて本発明を更に具体的に説明する。なお以下の例は、本発明を制限することなく、本発明を例示しようとするものである。 Hereinafter, the present invention will be described more specifically with reference to examples. The following examples are intended to illustrate the present invention without limiting the present invention.
(実施例1)
工程(1):化合物(3A)の合成
N−ブロモコハク酸イミド(NBS)8.67gと 臭素 10.11gと塩化メチレン100mLの混合液を氷浴で冷却した後、化合物(2A)25.09gと塩化メチレン50mLの混合液を 約30分かけて滴下した。その後、室温まで昇温させ2時間撹拌し、水100mLを滴下し、反応粗油を 5% チオ硫酸ナトリウム水溶液および水で洗浄した後、濃縮を行うことで化合物(3A)26.89gを得た。
(Example 1)
Step (1): Synthesis of Compound (3A)
A mixture of 8.67 g of N-bromosuccinimide (NBS), 10.11 g of bromine and 100 mL of methylene chloride was cooled in an ice bath, and then a mixture of 25.09 g of compound (2A) and 50 mL of methylene chloride was added over about 30 minutes. And dripped. Thereafter, the mixture was warmed to room temperature, stirred for 2 hours, 100 mL of water was added dropwise, the reaction crude oil was washed with 5% aqueous sodium thiosulfate solution and water, and then concentrated to obtain 26.89 g of Compound (3A). .
工程(2):化合物(1A)の合成
化合物(3A)16.69gと化合物(4A)3.89g、炭酸カリウム10.59g、DMF110mLの混合液を110℃まで昇温し、3時間撹拌。その後、80℃で一晩撹拌し、化合物(4A)1.89gと炭酸カリウム1.57g加え、120℃で8時間撹拌を行った。室温まで冷却後、水でクエンチ行い、ヘキサンで有機層を抽出し、5%炭酸水素ナトリウム水溶液および水で処理し後、濃縮を行った。得られた粗生成物をシリカクロマトグラフィーと再結晶で精製を行い化合物(1A)2.95gを得た。
Step (2): Synthesis of Compound (1A)
A mixture of 16.69 g of compound (3A), 3.89 g of compound (4A), 10.59 g of potassium carbonate, and 110 mL of DMF was heated to 110 ° C. and stirred for 3 hours. Then, it stirred at 80 degreeC overnight, 1.89 g of compounds (4A) and 1.57 g of potassium carbonate were added, and it stirred at 120 degreeC for 8 hours. After cooling to room temperature, it was quenched with water, the organic layer was extracted with hexane, treated with 5% aqueous sodium hydrogen carbonate solution and water, and then concentrated. The resulting crude product was purified by silica chromatography and recrystallization to obtain 2.95 g of compound (1A).
得られた化合物(1A)のNMR、相系列を以下に示す。
<NMR>
19F−NMR(282.6MHz、重溶媒CDCl3、基準CFCl3)δ(ppm):−76.03(d、2F)、−132.80(m、2F)、−135.56(m、1F)、−163.44(m、1F)。
1H NMR(282.6MHz、重溶媒CDCl3、基準SiMe4)δ(ppm):6.84(m、2H)、5.29(dd、1H)、2.8−0.7(m、br)。
<相系列>
C 33.0 N 47.7 I(C:結晶、N:ネマチック相、I:等方相)
The NMR and phase series of the obtained compound (1A) are shown below.
<NMR>
19 F-NMR (282.6 MHz, heavy solvent CDCl 3 , reference CFCl 3 ) δ (ppm): −76.03 (d, 2F), −132.80 (m, 2F), −135.56 (m, 1F), -163.44 (m, 1F).
1 H NMR (282.6 MHz, deuterated solvent CDCl 3 , reference SiMe 4 ) δ (ppm): 6.84 (m, 2H), 5.29 (dd, 1H), 2.8-0.7 (m, br).
<Phase series>
C 33.0 N 47.7 I (C: crystal, N: nematic phase, I: isotropic phase)
また、メルク社製液晶組成物ZLI−1565を母液晶として用い、化合物(1A)について下記物性を測定した。結果を表1に示す。 Moreover, the following physical property was measured about the compound (1A) using liquid crystal composition ZLI-1565 by Merck as a mother liquid crystal. The results are shown in Table 1.
[透明点]
偏光顕微鏡を備えた融点測定装置のホットプレート(メトラー社FP−82HT型ホットステージ)に、試料(目的化合物と母液晶との混合物)を置き、1℃/分の速度で加熱しながら偏光顕微鏡を観察した。試料の一部が液晶相から等方性液体に変化したときの温度を透明点(Tc)として、外挿により求めた。
[屈折率異方性(Δn)の測定]
化合物(1A)20質量%と母液晶80質量%との混合物を用いて、25℃における屈折率異方性(Δn)を外挿により求めた。
[Clear point]
Place the sample (mixture of the target compound and mother liquid crystal) on the hot plate (Mettler FP-82HT type hot stage) of the melting point measuring apparatus equipped with a polarizing microscope and heat the polarizing microscope while heating at a rate of 1 ° C / min. Observed. The temperature when a part of the sample was changed from a liquid crystal phase to an isotropic liquid was determined by extrapolation as a clearing point (Tc).
[Measurement of refractive index anisotropy (Δn)]
The refractive index anisotropy (Δn) at 25 ° C. was determined by extrapolation using a mixture of 20% by mass of the compound (1A) and 80% by mass of the mother liquid crystals.
[誘電率異方性(Δε)の測定]
化合物(1A)10モル%と母液晶90モル%との混合物を2枚のガラスセル(間隔8μm)の間に封入した。このセルに100mVの電圧を印加して液晶分子の短軸方向の誘電率(ε⊥)を測定した。88Vの電圧を印加して液晶分子の長軸方向の誘電率(ε‖)を測定した。
化合物の誘電率異方性(Δε)は式Δε=ε‖−ε⊥から組成物のΔεを求めて、外挿することで求めた。
0.85TcでのΔεを求めたところ、7.43であった。なお、0.85Tcは、液晶組成物のTc(絶対温度(K)に換算)に、0.85を乗じた温度(K)である。
[Measurement of dielectric anisotropy (Δε)]
A mixture of 10 mol% of the compound (1A) and 90 mol% of the mother liquid crystals was sealed between two glass cells (interval of 8 μm). A voltage of 100 mV was applied to the cell, and the dielectric constant (ε ⊥ ) in the minor axis direction of the liquid crystal molecules was measured. A voltage of 88 V was applied to measure the dielectric constant (ε ‖ ) in the major axis direction of the liquid crystal molecules.
Dielectric anisotropy of the compound ([Delta] [epsilon]) is seeking [Delta] [epsilon] of the composition from the equation [Delta] [epsilon] = epsilon ‖-epsilon ⊥, was determined by extrapolation.
When Δε at 0.85 Tc was determined, it was 7.43. Here, 0.85 Tc is a temperature (K) obtained by multiplying Tc (converted to absolute temperature (K)) of the liquid crystal composition by 0.85.
[バルク粘度の測定]
母液晶80質量%、化合物(1A)20質量%からなる液晶組成物を調整し、E型粘度計を用いて25℃および0℃にて測定後、外挿によって算出した。ところ、25℃で54.0mPa・s、0℃で109.5mPa・sであった。
[Measurement of bulk viscosity]
A liquid crystal composition comprising 80% by mass of the mother liquid crystal and 20% by mass of the compound (1A) was prepared, measured at 25 ° C. and 0 ° C. using an E-type viscometer, and calculated by extrapolation. However, it was 54.0 mPa · s at 25 ° C. and 109.5 mPa · s at 0 ° C.
以上のように、本発明の含フッ素液晶化合物は、粘度、Δε、TcおよびΔnの値について、液晶組成物の構成成分として用いるのに十分な値を有していることが分った。
このような本願化合物を液晶組成物に用いることで、液晶素子に要求される様々な性能を持つ組成物の調製ができることが明らかになった。
As described above, it has been found that the fluorine-containing liquid crystal compound of the present invention has sufficient values for the viscosity, Δε, Tc, and Δn to be used as components of the liquid crystal composition.
It has been clarified that by using such a compound of the present invention for a liquid crystal composition, a composition having various performances required for a liquid crystal element can be prepared.
(実施例2)
実施例1および前述したスキームに基づいて、下記化合物を製造することができる。下記式中、−Cy−、−Ph−は上記と同様であり、他の記号は以下の意味を示す。
−Ph(2F)−:2−フルオロ−1,4−フェニレン基
−Ph(2F,6F)−:2,6−ジフルオロ−1,4−フェニレン基
−Ph(2F,3F)−:2,3−ジフルオロ−1,4−フェニレン基
また、式(1)中のA1〜A7に相当する置換型環基の置換位置は、環員炭素がR1に近いほうを常に4位、R2に近い方を常に1位とする場合に相当する。
(Example 2)
Based on Example 1 and the scheme described above, the following compounds can be prepared. In the following formulae, -Cy- and -Ph- are the same as described above, and other symbols have the following meanings.
-Ph (2F)-: 2-fluoro-1,4-phenylene group-Ph (2F, 6F)-: 2,6-difluoro-1,4-phenylene group-Ph (2F, 3F)-: 2,3 -Difluoro-1,4-phenylene group Moreover, the substitution position of the substituted ring group corresponding to A 1 to A 7 in the formula (1) is always the 4-position when the ring member carbon is closer to R 1 , R 2 This is equivalent to the case where the one near is always the first place.
2環の化合物(a〜eが全て0であるもの。)としては以下のものが挙げられる。 Examples of the bicyclic compound (where all of a to e are 0) include the following.
C3H7-Ph-CH=CFCF2O-Ph-C2H5
C3H7-Ph-CH=CFCF2O-Ph-F
C3H7-Ph-CH=CFCF2O-Ph(2F)-F
C3H7-Ph-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Ph-CH=CFCF2O-Ph(2F,6F)-CN
C3H7-Ph-CH=CFCF2O-Ph(2F,6F)-NCS
C3H7-Ph-CH=CFCF2O-Ph(2F,6F)-SF5
C3H7-Ph-CH=CFCF2O-Ph(2F)-OCF3
C3H7O-Ph-CH=CFCF2O-Ph(2F)-OCF3
C2H5-Ph-CH=CFCF2O-Ph(2F,3F)-OCH3
C5H11-Ph-CH=CFCF2O-Ph(2F,6F)-OCF2H
CH3CH=CH-C2H4-Ph-CH=CFCF2O-Ph(2F,6F)-F
CH3OCH2-Ph-CH=CFCF2O-Ph(2F,3F)-F
C3H7O-Ph(2F,3F)-CH=CFCF2O-Ph(2F,3F)-F
C 3 H 7 -Ph-CH = CFCF 2 O-Ph-C 2 H 5
C 3 H 7 -Ph-CH = CFCF 2 O-Ph-F
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F) -F
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F, 6F) -CN
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F, 6F) -NCS
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F, 6F) -SF 5
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F) -OCF 3
C 3 H 7 O-Ph-CH = CFCF 2 O-Ph (2F) -OCF 3
C 2 H 5 -Ph-CH = CFCF 2 O-Ph (2F, 3F) -OCH 3
C 5 H 11 -Ph-CH = CFCF 2 O-Ph (2F, 6F) -OCF 2 H
CH 3 CH = CH-C 2 H 4 -Ph-CH = CFCF 2 O-Ph (2F, 6F) -F
CH 3 OCH 2 -Ph-CH = CFCF 2 O-Ph (2F, 3F) -F
C 3 H 7 O-Ph (2F, 3F) -CH = CFCF 2 O-Ph (2F, 3F) -F
C3H7-Cy-CH=CFCF2O-Ph-C2H5
C3H7-Cy-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Cy-CH=CFCF2O-Ph(2F,6F)-CN
C3H7O-Cy-CH=CFCF2O-Ph(2F)-OCF3
C2H5-Cy-CH=CFCF2O-Ph(2F,3F)-OCH3
CH3CH=CH-C2H4-Cy-CH=CFCF2O-Ph(2F,6F)-F
CH2=CH-Cy-CH=CFCF2O-Ph(2F,6F)-F
C5H11-Cy-CH=CFCF2O-Ph(2F,6F)-OCF2H
C 3 H 7 -Cy-CH = CFCF 2 O-Ph-C 2 H 5
C 3 H 7 -Cy-CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Cy-CH = CFCF 2 O-Ph (2F, 6F) -CN
C 3 H 7 O-Cy-CH = CFCF 2 O-Ph (2F) -OCF 3
C 2 H 5 -Cy-CH = CFCF 2 O-Ph (2F, 3F) -OCH 3
CH 3 CH = CH-C 2 H 4 -Cy-CH = CFCF 2 O-Ph (2F, 6F) -F
CH 2 = CH-Cy-CH = CFCF 2 O-Ph (2F, 6F) -F
C 5 H 11 -Cy-CH = CFCF 2 O-Ph (2F, 6F) -OCF 2 H
3環の化合物(a〜eの何れか1つが1であり、他の3つが0であるもの。)としては以下のものが挙げられる。 Examples of the tricyclic compound (one in which any one of a to e is 1 and the other 3 are 0) include the following.
C3H7-Cy-Ph-CH=CFCF2O-Ph-C2H5
C3H7-Cy-Ph-CH=CFCF2O-Ph-F
C3H7-Cy-Ph-CH=CFCF2O-Ph(2F)-F
C3H7-Cy-Ph-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Cy-Ph-CH=CFCF2O-Ph(2F,6F)-CN
C2H5-Cy-Ph-CH=CFCF2O-Ph(2F,6F)-NCS
C3H7-Cy-Ph-CH=CFCF2O-Ph(2F,6F)-SF5
C5H11-Cy-Ph-CH=CFCF2O-Ph(2F,6F)-OCF3
C3H7-Cy-Ph-CH=CFCF2O-Ph(2F,3F)-OC2H5
C2H5-Cy-Ph(2F,3F)-CH=CFCF2O-Ph(2F,3F)-OC2H5
C3H7-Cy-Ph(2F)-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Cy-Ph(2F,6F)-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Cy-Ph(2F,6F)-CH=CFCF2O-Ph(2F,6F)-OCF3
C3H7-Cy-Ph(2F,6F)-CH=CFCF2O-Ph(2F,6F)-CN
C 3 H 7 -Cy-Ph-CH = CFCF 2 O-Ph-C 2 H 5
C 3 H 7 -Cy-Ph-CH = CFCF 2 O-Ph-F
C 3 H 7 -Cy-Ph-CH = CFCF 2 O-Ph (2F) -F
C 3 H 7 -Cy-Ph-CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Cy-Ph-CH = CFCF 2 O-Ph (2F, 6F) -CN
C 2 H 5 -Cy-Ph-CH = CFCF 2 O-Ph (2F, 6F) -NCS
C 3 H 7 -Cy-Ph-CH = CFCF 2 O-Ph (2F, 6F) -SF 5
C 5 H 11 -Cy-Ph-CH = CFCF 2 O-Ph (2F, 6F) -OCF 3
C 3 H 7 -Cy-Ph-CH = CFCF 2 O-Ph (2F, 3F) -OC 2 H 5
C 2 H 5 -Cy-Ph (2F, 3F) -CH = CFCF 2 O-Ph (2F, 3F) -OC 2 H 5
C 3 H 7 -Cy-Ph (2F) -CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Cy-Ph (2F, 6F) -CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Cy-Ph (2F, 6F) -CH = CFCF 2 O-Ph (2F, 6F) -OCF 3
C 3 H 7 -Cy-Ph (2F, 6F) -CH = CFCF 2 O-Ph (2F, 6F) -CN
C2H5-Ph-Ph-CH=CFCF2O-Ph-F
C3H7-Ph-Ph-CH=CFCF2O-Ph(2F)-F
C3H7-Ph-Ph-CH=CFCF2O-Ph(2F,6F)-F
C5H11-Ph-Ph-CH=CFCF2O-Ph(2F,6F)-CN
C3H7-Ph-Ph-CH=CFCF2O-Ph(2F,6F)-NCS
C3H7-Ph-Ph-CH=CFCF2O-Ph(2F,6F)-SF5
C3H7-Ph-Ph-CH=CFCF2O-Ph(2F,6F)-OCF3
C2H5-Ph-Ph-CH=CFCF2O-Ph(2F,3F)-OC2H5
C3H7-Ph-Ph(2F,3F)-CH=CFCF2O-Ph(2F,3F)-OC2H5
C3H7-Ph-Ph(2F)-CH=CFCF2O-Ph(2F,6F)-F
C5H11-Ph-Ph(2F,6F)-CH=CFCF2O-Ph(2F,6F)-F
C 2 H 5 -Ph-Ph-CH = CFCF 2 O-Ph-F
C 3 H 7 -Ph-Ph-CH = CFCF 2 O-Ph (2F) -F
C 3 H 7 -Ph-Ph-CH = CFCF 2 O-Ph (2F, 6F) -F
C 5 H 11 -Ph-Ph-CH = CFCF 2 O-Ph (2F, 6F) -CN
C 3 H 7 -Ph-Ph-CH = CFCF 2 O-Ph (2F, 6F) -NCS
C 3 H 7 -Ph-Ph-CH = CFCF 2 O-Ph (2F, 6F) -SF 5
C 3 H 7 -Ph-Ph-CH = CFCF 2 O-Ph (2F, 6F) -OCF 3
C 2 H 5 -Ph-Ph-CH = CFCF 2 O-Ph (2F, 3F) -OC 2 H 5
C 3 H 7 -Ph-Ph (2F, 3F) -CH = CFCF 2 O-Ph (2F, 3F) -OC 2 H 5
C 3 H 7 -Ph-Ph (2F) -CH = CFCF 2 O-Ph (2F, 6F) -F
C 5 H 11 -Ph-Ph (2F, 6F) -CH = CFCF 2 O-Ph (2F, 6F) -F
C3H7-Cy-Cy-CH=CFCF2O-Ph-F
CH2=CH-Cy-Cy-CH=CFCF2O-Ph(2F)-F
C3H7-Cy-Cy-CH=CFCF2O-Ph(2F)-OCF3
C3H7-Cy-Cy-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Cy-Cy-CH=CFCF2O-Ph(2F,6F)-CN
C5H11-Cy-Cy-CH=CFCF2O-Ph(2F,3F)-OC2H5
C5H11-Cy-Cy-CH=CFCF2O-Ph(2F,6F)-OCF2H
C 3 H 7 -Cy-Cy-CH = CFCF 2 O-Ph-F
CH 2 = CH-Cy-Cy-CH = CFCF 2 O-Ph (2F) -F
C 3 H 7 -Cy-Cy-CH = CFCF 2 O-Ph (2F) -OCF 3
C 3 H 7 -Cy-Cy-CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Cy-Cy-CH = CFCF 2 O-Ph (2F, 6F) -CN
C 5 H 11 -Cy-Cy-CH = CFCF 2 O-Ph (2F, 3F) -OC 2 H 5
C 5 H 11 -Cy-Cy-CH = CFCF 2 O-Ph (2F, 6F) -OCF 2 H
C2H5-Ph-CH=CFCF2O-Ph-Ph(2F)-F
C3H7-Ph-CH=CFCF2O-Ph-Ph(2F,6F)-F
C3H7-Ph-CH=CFCF2O-Ph(2F,6F)-Ph(2F,6F)-F
C5H11-Ph-CH=CFCF2O-Ph(2F,6F)-Ph(2F,6F)-CN
CH3CH=CHC2H4-Ph-CH=CFCF2O-Ph-Ph(2F)-F
C3H7-Ph-CH=CFCF2O-Ph-Ph(2F,3F)-OCH3
C3H7-Ph(2F)-CH=CFCF2O-Ph-Ph(2F,6F)-F
C2H5-Ph-CH=CFCF2O-Ph-Cy-C5H11
C2H5-Ph-CH=CFCF2O-Ph(2F)-Cy-C5H11
C3H7-Ph-CH=CFCF2O-Ph(2F,6F)-Cy-C5H11
C3H7-Ph(2F,3F)-CH=CFCF2O-Ph-Cy-OC2H5
C2H5-Cy-CH=CFCF2O-Ph-Ph(2F)-F
C5H11-Cy-CH=CFCF2O-Ph-Ph(2F,6F)-F
C3H7-Cy-CH=CFCF2O-Ph(2F,6F)-Ph(2F)-OCF3
C3H7-Cy-CH=CFCF2O-Ph(2F,6F)-Ph(2F,6F)-F
C5H11-Cy-CH=CFCF2O-Ph(2F,6F)-Ph(2F,6F)-CN
C3H7-Cy-CH=CFCF2O-Ph-Ph(2F,3F)-OC2H5
C 2 H 5 -Ph-CH = CFCF 2 O-Ph-Ph (2F) -F
C 3 H 7 -Ph-CH = CFCF 2 O-Ph-Ph (2F, 6F) -F
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F, 6F) -Ph (2F, 6F) -F
C 5 H 11 -Ph-CH = CFCF 2 O-Ph (2F, 6F) -Ph (2F, 6F) -CN
CH 3 CH = CHC 2 H 4 -Ph-CH = CFCF 2 O-Ph-Ph (2F) -F
C 3 H 7 -Ph-CH = CFCF 2 O-Ph-Ph (2F, 3F) -OCH 3
C 3 H 7 -Ph (2F) -CH = CFCF 2 O-Ph-Ph (2F, 6F) -F
C 2 H 5 -Ph-CH = CFCF 2 O-Ph-Cy-C 5 H 11
C 2 H 5 -Ph-CH = CFCF 2 O-Ph (2F) -Cy-C 5 H 11
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F, 6F) -Cy-C 5 H 11
C 3 H 7 -Ph (2F, 3F) -CH = CFCF 2 O-Ph-Cy-OC 2 H 5
C 2 H 5 -Cy-CH = CFCF 2 O-Ph-Ph (2F) -F
C 5 H 11 -Cy-CH = CFCF 2 O-Ph-Ph (2F, 6F) -F
C 3 H 7 -Cy-CH = CFCF 2 O-Ph (2F, 6F) -Ph (2F) -OCF 3
C 3 H 7 -Cy-CH = CFCF 2 O-Ph (2F, 6F) -Ph (2F, 6F) -F
C 5 H 11 -Cy-CH = CFCF 2 O-Ph (2F, 6F) -Ph (2F, 6F) -CN
C 3 H 7 -Cy-CH = CFCF 2 O-Ph-Ph (2F, 3F) -OC 2 H 5
C3H7-Cy-C2H4-Ph-CH=CFCF2O-Ph(2F)-F
C3H7-Cy-C2H4-Ph(2F)-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Cy-C2H4-Ph(2F)-CH=CFCF2O-Ph(2F,6F)-OCF3
CH3CH=CHC2H4-Cy-C2H4-Ph-CH=CFCF2O-Ph(2F)-C3H7
CH2=CH-Cy-CH2O-Ph-CH=CFCF2O-Ph(2F)-F
C3H7-Cy-CH2O-Ph(2F,3F)-CH=CFCF2O-Ph(2F,3F)-OC2H5
C 3 H 7 -Cy-C 2 H 4 -Ph-CH = CFCF 2 O-Ph (2F) -F
C 3 H 7 -Cy-C 2 H 4 -Ph (2F) -CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Cy-C 2 H 4 -Ph (2F) -CH = CFCF 2 O-Ph (2F, 6F) -OCF 3
CH 3 CH = CHC 2 H 4 -Cy-C 2 H 4 -Ph-CH = CFCF 2 O-Ph (2F) -C 3 H 7
CH 2 = CH-Cy-CH 2 O-Ph-CH = CFCF 2 O-Ph (2F) -F
C 3 H 7 -Cy-CH 2 O-Ph (2F, 3F) -CH = CFCF 2 O-Ph (2F, 3F) -OC 2 H 5
4環の化合物(a〜eの何れか2つが1であり、他の2つが0であるもの。)としては以下のものが挙げられる。 Examples of the tetracyclic compound (one in which any two of a to e are 1 and the other two are 0) include the following.
C3H7-Ph-CH=CFCF2O-Ph-Ph-Ph-C2H5
C3H7-Ph-CH=CFCF2O-Ph-Ph-Ph(2F,6F)-F
C2H5-Ph-CH=CFCF2O-Ph-Ph(2F,6F)-Ph(2F)-F
C5H11-Ph-CH=CFCF2O-Ph(2F)-Ph(2F)-Ph(2F)-CN
C5H11-Ph-CH=CFCF2O-Ph(2F)-Ph(2F,6F)-Ph(2F)-OCF3
C3H7-Ph-CH=CFCF2O-Ph(2F,6F)-Ph(2F,6F)-Ph(2F,6F)-F
C2H5-Ph(2F)-CH=CFCF2O-Ph-Ph(2F,6F)-Ph(2F)-CN
C2H5-Ph(2F,3F)-CH=CFCF2O-Ph-Ph-Ph(2F)-F
C 3 H 7 -Ph-CH = CFCF 2 O-Ph-Ph-Ph-C 2 H 5
C 3 H 7 -Ph-CH = CFCF 2 O-Ph-Ph-Ph (2F, 6F) -F
C 2 H 5 -Ph-CH = CFCF 2 O-Ph-Ph (2F, 6F) -Ph (2F) -F
C 5 H 11 -Ph-CH = CFCF 2 O-Ph (2F) -Ph (2F) -Ph (2F) -CN
C 5 H 11 -Ph-CH = CFCF 2 O-Ph (2F) -Ph (2F, 6F) -Ph (2F) -OCF 3
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F, 6F) -Ph (2F, 6F) -Ph (2F, 6F) -F
C 2 H 5 -Ph (2F) -CH = CFCF 2 O-Ph-Ph (2F, 6F) -Ph (2F) -CN
C 2 H 5 -Ph (2F, 3F) -CH = CFCF 2 O-Ph-Ph-Ph (2F) -F
C3H7-Cy-CH=CFCF2O-Ph-Ph-Ph-C2H5
C3H7-Cy-CH=CFCF2O-Ph-Ph-Ph(2F,6F)-F
C2H5-Cy-CH=CFCF2O-Ph-Ph(2F,3F)-Ph(2F,3F)-OC2H5
C5H11-Cy-CH=CFCF2O-Ph(2F)-Ph(2F)-Ph(2F)-CN
C5H11-Cy-CH=CFCF2O-Ph(2F)-Ph(2F,6F)-Ph(2F)-OCF3
C3H7-Cy-CH=CFCF2O-Ph(2F,6F)-Ph(2F,6F)-Ph(2F,6F)-F
C2H5-Cy-CH=CFCF2O-Ph-Ph(2F,6F)-Ph(2F)-CN
C 3 H 7 -Cy-CH = CFCF 2 O-Ph-Ph-Ph-C 2 H 5
C 3 H 7 -Cy-CH = CFCF 2 O-Ph-Ph-Ph (2F, 6F) -F
C 2 H 5 -Cy-CH = CFCF 2 O-Ph-Ph (2F, 3F) -Ph (2F, 3F) -OC 2 H 5
C 5 H 11 -Cy-CH = CFCF 2 O-Ph (2F) -Ph (2F) -Ph (2F) -CN
C 5 H 11 -Cy-CH = CFCF 2 O-Ph (2F) -Ph (2F, 6F) -Ph (2F) -OCF 3
C 3 H 7 -Cy-CH = CFCF 2 O-Ph (2F, 6F) -Ph (2F, 6F) -Ph (2F, 6F) -F
C 2 H 5 -Cy-CH = CFCF 2 O-Ph-Ph (2F, 6F) -Ph (2F) -CN
C3H7-Ph-CH=CFCF2O-Ph(2F,3F)-Ph(2F,3F)-Cy-C2H5
C3H7-Ph-CH=CFCF2O-Ph(2F,6F)-Ph(2F,6F)-Cy-CH=CH2
C3H7-Ph(2F,3F)-CH=CFCF2O-Ph(2F,3F)-Ph(2F,3F)-Cy-CH3
C3H7-Ph-CH=CFCF2O-Ph(2F,3F)-Cy-Cy-C2H5
C3H7-Ph-CH=CFCF2O-Ph(2F,6F)-Cy-Cy-OCH3
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F, 3F) -Ph (2F, 3F) -Cy-C 2 H 5
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F, 6F) -Ph (2F, 6F) -Cy-CH = CH 2
C 3 H 7 -Ph (2F, 3F) -CH = CFCF 2 O-Ph (2F, 3F) -Ph (2F, 3F) -Cy-CH 3
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F, 3F) -Cy-Cy-C 2 H 5
C 3 H 7 -Ph-CH = CFCF 2 O-Ph (2F, 6F) -Cy-Cy-OCH 3
C3H7-Cy-Ph-CH=CFCF2O-Ph-Ph-C2H5
C3H7-Cy-Ph-CH=CFCF2O-Ph(2F)-Ph(2F,6F)-F
C5H11-Cy-Ph-CH=CFCF2O-Ph(2F,6F)-Ph(2F,6F)-OCF3
C3H7-Cy-Ph-CH=CFCF2O-Ph-Cy-CH=CH2
C5H11-Cy-Ph-CH=CFCF2O-Ph(2F,3F)-Cy-C2H5
C3H7-Cy-Ph(2F,3F)-CH=CFCF2O-Ph(2F,3F)-Cy-C2H5
C3H7-Cy-Cy-CH=CFCF2O-Ph-Ph(2F)-F
C5H11-Cy-Cy-CH=CFCF2O-Ph(2F)-Ph(2F,6F)-CN
C5H11-Cy-Cy-CH=CFCF2O-Ph(2F,3F)-Ph(2F,3F)-OC2H5
C5H11-Cy-Cy-CH=CFCF2O-Ph(2F)-Cy-C3H7
C3H7-Cy-Cy-CH=CFCF2O-Ph(2F,6F)-Cy-OC2H5
C3H7-Cy-Cy-CH=CFCF2O-Ph(2F,3F)-Cy-OCH3
C 3 H 7 -Cy-Ph-CH = CFCF 2 O-Ph-Ph-C 2 H 5
C 3 H 7 -Cy-Ph-CH = CFCF 2 O-Ph (2F) -Ph (2F, 6F) -F
C 5 H 11 -Cy-Ph-CH = CFCF 2 O-Ph (2F, 6F) -Ph (2F, 6F) -OCF 3
C 3 H 7 -Cy-Ph-CH = CFCF 2 O-Ph-Cy-CH = CH 2
C 5 H 11 -Cy-Ph-CH = CFCF 2 O-Ph (2F, 3F) -Cy-C 2 H 5
C 3 H 7 -Cy-Ph (2F, 3F) -CH = CFCF 2 O-Ph (2F, 3F) -Cy-C 2 H 5
C 3 H 7 -Cy-Cy-CH = CFCF 2 O-Ph-Ph (2F) -F
C 5 H 11 -Cy-Cy-CH = CFCF 2 O-Ph (2F) -Ph (2F, 6F) -CN
C 5 H 11 -Cy-Cy-CH = CFCF 2 O-Ph (2F, 3F) -Ph (2F, 3F) -OC 2 H 5
C 5 H 11 -Cy-Cy-CH = CFCF 2 O-Ph (2F) -Cy-C 3 H 7
C 3 H 7 -Cy-Cy-CH = CFCF 2 O-Ph (2F, 6F) -Cy-OC 2 H 5
C 3 H 7 -Cy-Cy-CH = CFCF 2 O-Ph (2F, 3F) -Cy-OCH 3
C3H7-Ph-Ph-Ph-CH=CFCF2O-Ph(2F)-OCF3
C3H7-Ph-Ph-Ph(2F,6F)-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Ph-Ph(2F)-Ph(2F,6F)-CH=CFCF2O-Ph(2F,6F)-CN
C2H5-Ph-Ph(2F,6F)-Ph-CH=CFCF2O-Ph(2F)-CN
CH3-CH=CH-C2H4-Ph-Ph-Ph-CH=CFCF2O-Ph(2F)-F
CH2=CH-Cy-Cy-Cy-CH=CFCF2O-Ph(2F)-OCF3
C3H7-Cy-Cy-Cy-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Cy-Cy-Cy-CH=CFCF2O-Ph(2F,3F)-OC2H5
C2H5O-Cy-Cy-Ph-CH=CFCF2O-Ph(2F)-OCF3
C3H7-Cy-Cy-Ph-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Cy-Cy-Ph(2F)-CH=CFCF2O-Ph(2F,6F)-CN
C3H7-Cy-Cy-Ph-CH=CFCF2O-Ph(2F,3F)-OC2H5
C3H7-Cy-Ph-Ph-CH=CFCF2O-Ph(2F)-OCF3
C3H7-Cy-Ph-Ph(2F,6F)-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Cy-Ph(2F)-Ph(2F,6F)-CH=CFCF2O-Ph(2F,6F)-CN
C2H5-Cy-Ph(2F,6F)-Ph-CH=CFCF2O-Ph(2F)-CN
CH2=CH-Cy-Ph-Ph-CH=CFCF2O-Ph(2F)-F
C 3 H 7 -Ph-Ph-Ph-CH = CFCF 2 O-Ph (2F) -OCF 3
C 3 H 7 -Ph-Ph-Ph (2F, 6F) -CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Ph-Ph (2F) -Ph (2F, 6F) -CH = CFCF 2 O-Ph (2F, 6F) -CN
C 2 H 5 -Ph-Ph (2F, 6F) -Ph-CH = CFCF 2 O-Ph (2F) -CN
CH 3 -CH = CH-C 2 H 4 -Ph-Ph-Ph-CH = CFCF 2 O-Ph (2F) -F
CH 2 = CH-Cy-Cy-Cy-CH = CFCF 2 O-Ph (2F) -OCF 3
C 3 H 7 -Cy-Cy-Cy-CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Cy-Cy-Cy-CH = CFCF 2 O-Ph (2F, 3F) -OC 2 H 5
C 2 H 5 O-Cy-Cy-Ph-CH = CFCF 2 O-Ph (2F) -OCF 3
C 3 H 7 -Cy-Cy-Ph-CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Cy-Cy-Ph (2F) -CH = CFCF 2 O-Ph (2F, 6F) -CN
C 3 H 7 -Cy-Cy-Ph-CH = CFCF 2 O-Ph (2F, 3F) -OC 2 H 5
C 3 H 7 -Cy-Ph-Ph-CH = CFCF 2 O-Ph (2F) -OCF 3
C 3 H 7 -Cy-Ph-Ph (2F, 6F) -CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Cy-Ph (2F) -Ph (2F, 6F) -CH = CFCF 2 O-Ph (2F, 6F) -CN
C 2 H 5 -Cy-Ph (2F, 6F) -Ph-CH = CFCF 2 O-Ph (2F) -CN
CH 2 = CH-Cy-Ph-Ph-CH = CFCF 2 O-Ph (2F) -F
5環の化合物(a〜eの何れか3つが1であり、他の2つが0であるもの。)としては以下のものが挙げられる。 Examples of the pentacyclic compound (one in which any three of a to e are 1 and the other two are 0) include the following.
C3H7-Ph-Ph-Ph-Ph-CH=CFCF2O-Ph(2F)-F
C3H7-Ph-Ph-Ph-Ph(2F,6F)-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Ph-Ph-Ph(2F)-Ph(2F,6F)-CH=CFCF2O-Ph(2F,6F)-CN
C2H5-Ph-Ph-Ph(2F,6F)-Ph-CH=CFCF2O-Ph(2F)-CN
CH3-CH=CH-C2H4-Ph-Ph-Ph-Ph-CH=CFCF2O-Ph(2F)-F
CH2=CH-Cy-Cy-Cy-Ph-CH=CFCF2O-Ph(2F)-OCF3
C3H7-Cy-Cy-Cy-Ph-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Cy-Cy-Cy-Ph-CH=CFCF2O-Ph(2F,3F)-OC2H5
C2H5O-Cy-Cy-Ph-Ph-CH=CFCF2O-Ph(2F)-OCF3
C3H7-Cy-Cy-Ph-Ph-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Cy-Cy-Ph-Ph(2F)-CH=CFCF2O-Ph(2F,6F)-CN
C3H7-Cy-Cy-Ph-Ph-CH=CFCF2O-Ph(2F,3F)-OC2H5
C3H7-Cy-Ph-Ph-Ph-CH=CFCF2O-Ph(2F)-OCF3
C3H7-Cy-Ph-Ph-Ph(2F,6F)-CH=CFCF2O-Ph(2F,6F)-F
C3H7-Cy-Ph-Ph(2F)-Ph(2F,6F)-CH=CFCF2O-Ph(2F,6F)-CN
C2H5-Cy-Ph-Ph(2F,6F)-Ph-CH=CFCF2O-Ph(2F)-CN
C3H7-Cy-Ph-Ph-Ph-CH=CFCF2O-Ph(2F,6F)-F
CH2=CH-Cy-Ph-Ph-Ph-CH=CFCF2O-Ph(2F)-F
C 3 H 7 -Ph-Ph-Ph-Ph-CH = CFCF 2 O-Ph (2F) -F
C 3 H 7 -Ph-Ph-Ph-Ph (2F, 6F) -CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Ph-Ph-Ph (2F) -Ph (2F, 6F) -CH = CFCF 2 O-Ph (2F, 6F) -CN
C 2 H 5 -Ph-Ph-Ph (2F, 6F) -Ph-CH = CFCF 2 O-Ph (2F) -CN
CH 3 -CH = CH-C 2 H 4 -Ph-Ph-Ph-Ph-CH = CFCF 2 O-Ph (2F) -F
CH 2 = CH-Cy-Cy-Cy-Ph-CH = CFCF 2 O-Ph (2F) -OCF 3
C 3 H 7 -Cy-Cy-Cy-Ph-CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Cy-Cy-Cy-Ph-CH = CFCF 2 O-Ph (2F, 3F) -OC 2 H 5
C 2 H 5 O-Cy-Cy-Ph-Ph-CH = CFCF 2 O-Ph (2F) -OCF 3
C 3 H 7 -Cy-Cy-Ph-Ph-CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Cy-Cy-Ph-Ph (2F) -CH = CFCF 2 O-Ph (2F, 6F) -CN
C 3 H 7 -Cy-Cy-Ph-Ph-CH = CFCF 2 O-Ph (2F, 3F) -OC 2 H 5
C 3 H 7 -Cy-Ph-Ph-Ph-CH = CFCF 2 O-Ph (2F) -OCF 3
C 3 H 7 -Cy-Ph-Ph-Ph (2F, 6F) -CH = CFCF 2 O-Ph (2F, 6F) -F
C 3 H 7 -Cy-Ph-Ph (2F) -Ph (2F, 6F) -CH = CFCF 2 O-Ph (2F, 6F) -CN
C 2 H 5 -Cy-Ph-Ph (2F, 6F) -Ph-CH = CFCF 2 O-Ph (2F) -CN
C 3 H 7 -Cy-Ph-Ph-Ph-CH = CFCF 2 O-Ph (2F, 6F) -F
CH 2 = CH-Cy-Ph-Ph-Ph-CH = CFCF 2 O-Ph (2F) -F
C3H7-Ph-Ph-Ph-CH=CFCF2O-Ph-Ph(2F)-F
C3H7-Ph-Ph-Ph(2F,6F)-CH=CFCF2O-Ph-Ph(2F,6F)-F
C3H7-Ph-Ph(2F)-Ph(2F,6F)-CH=CFCF2O-Ph-Ph(2F,6F)-CN
C2H5-Ph-Ph(2F,6F)-Ph-CH=CFCF2O-Ph-Ph(2F)-CN
CH3-CH=CH-C2H4-Ph-Ph-Ph-CH=CFCF2O-Ph-Ph(2F)-F
CH2=CH-Cy-Cy-Cy-CH=CFCF2O-Ph-Ph(2F)-OCF3
C3H7-Cy-Cy-Cy-CH=CFCF2O-Ph-Ph(2F,6F)-F
C3H7-Cy-Cy-Cy-CH=CFCF2O-Ph-Ph(2F,3F)-OC2H5
C2H5O-Cy-Cy-Ph-CH=CFCF2O-Ph-Ph(2F)-OCF3
C3H7-Cy-Cy-Ph-CH=CFCF2O-Ph-Ph(2F,6F)-F
C3H7-Cy-Cy-Ph(2F)-CH=CFCF2O-Ph-Ph(2F,6F)-CN
C3H7-Cy-Cy-Ph-CH=CFCF2O-Ph-Ph(2F,3F)-OC2H5
C3H7-Cy-Ph-Ph-CH=CFCF2O-Ph-Ph(2F)-OCF3
C3H7-Cy-Ph-Ph(2F,6F)-CH=CFCF2O-Ph-Ph(2F,6F)-F
C3H7-Cy-Ph(2F)-Ph(2F,6F)-CH=CFCF2O-Ph-Ph(2F,6F)-CN
C2H5-Cy-Ph(2F,6F)-Ph-CH=CFCF2O-Ph-Ph(2F)-CN
C3H7-Cy-Ph-Ph-CH=CFCF2O-Ph-Ph(2F,6F)-F
CH2=CH-Cy-Ph-Ph-CH=CFCF2O-Ph-Ph(2F)-F
C 3 H 7 -Ph-Ph-Ph-CH = CFCF 2 O-Ph-Ph (2F) -F
C 3 H 7 -Ph-Ph-Ph (2F, 6F) -CH = CFCF 2 O-Ph-Ph (2F, 6F) -F
C 3 H 7 -Ph-Ph (2F) -Ph (2F, 6F) -CH = CFCF 2 O-Ph-Ph (2F, 6F) -CN
C 2 H 5 -Ph-Ph (2F, 6F) -Ph-CH = CFCF 2 O-Ph-Ph (2F) -CN
CH 3 -CH = CH-C 2 H 4 -Ph-Ph-Ph-CH = CFCF 2 O-Ph-Ph (2F) -F
CH 2 = CH-Cy-Cy-Cy-CH = CFCF 2 O-Ph-Ph (2F) -OCF 3
C 3 H 7 -Cy-Cy-Cy-CH = CFCF 2 O-Ph-Ph (2F, 6F) -F
C 3 H 7 -Cy-Cy-Cy-CH = CFCF 2 O-Ph-Ph (2F, 3F) -OC 2 H 5
C 2 H 5 O-Cy-Cy-Ph-CH = CFCF 2 O-Ph-Ph (2F) -OCF 3
C 3 H 7 -Cy-Cy-Ph-CH = CFCF 2 O-Ph-Ph (2F, 6F) -F
C 3 H 7 -Cy-Cy-Ph (2F) -CH = CFCF 2 O-Ph-Ph (2F, 6F) -CN
C 3 H 7 -Cy-Cy-Ph-CH = CFCF 2 O-Ph-Ph (2F, 3F) -OC 2 H 5
C 3 H 7 -Cy-Ph-Ph-CH = CFCF 2 O-Ph-Ph (2F) -OCF 3
C 3 H 7 -Cy-Ph-Ph (2F, 6F) -CH = CFCF 2 O-Ph-Ph (2F, 6F) -F
C 3 H 7 -Cy-Ph (2F) -Ph (2F, 6F) -CH = CFCF 2 O-Ph-Ph (2F, 6F) -CN
C 2 H 5 -Cy-Ph (2F, 6F) -Ph-CH = CFCF 2 O-Ph-Ph (2F) -CN
C 3 H 7 -Cy-Ph-Ph-CH = CFCF 2 O-Ph-Ph (2F, 6F) -F
CH 2 = CH-Cy-Ph-Ph-CH = CFCF 2 O-Ph-Ph (2F) -F
C3H7-Ph-Ph-CH=CFCF2O-Ph-Ph-Ph(2F)-F
C3H7-Ph-Ph(2F,6F)-CH=CFCF2O-Ph-Ph-Ph(2F,6F)-F
C3H7-Ph(2F)-Ph(2F,6F)-CH=CFCF2O-Ph-Ph-Ph(2F,6F)-CN
C2H5-Ph(2F,6F)-Ph-CH=CFCF2O-Ph-Ph-Ph(2F)-CN
CH3-CH=CH-C2H4-Ph-Ph-CH=CFCF2O-Ph-Ph-Ph(2F)-F
CH2=CH-Cy-Cy-CH=CFCF2O-Ph-Cy-Ph(2F)-OCF3
C3H7-Cy-Cy-CH=CFCF2O-Ph-Cy-Ph(2F,6F)-F
C3H7-Cy-Cy-CH=CFCF2O-Ph-Cy-Ph(2F,3F)-OC2H5
C2H5O-Cy-Cy-CH=CFCF2O-Ph-Ph-Ph(2F)-OCF3
C3H7-Cy-Cy-CH=CFCF2O-Ph-Ph-Ph(2F,6F)-F
C3H7-Cy-Cy-CH=CFCF2O-Ph-Ph(2F)-Ph(2F,6F)-CN
C3H7-Cy-Cy-CH=CFCF2O-Ph-Ph-Ph(2F,3F)-OC2H5
C3H7-Cy-Ph-CH=CFCF2O-Ph-Ph-Ph(2F)-OCF3
C3H7-Cy-Ph(2F,6F)-CH=CFCF2O-Ph-Ph-Ph(2F,6F)-F
C3H7-Cy-Ph(2F)-CH=CFCF2O-Ph-Ph(2F,6F)-Ph(2F,6F)-CN
C2H5-Cy-Ph(2F,6F)-CH=CFCF2O-Ph-Ph-Ph(2F)-CN
C3H7-Cy-Ph-CH=CFCF2O-Ph-Ph-Ph(2F,6F)-F
CH2=CH-Cy-Ph-CH=CFCF2O-Ph-Ph-Ph(2F)-F
C 3 H 7 -Ph-Ph-CH = CFCF 2 O-Ph-Ph-Ph (2F) -F
C 3 H 7 -Ph-Ph (2F, 6F) -CH = CFCF 2 O-Ph-Ph-Ph (2F, 6F) -F
C 3 H 7 -Ph (2F) -Ph (2F, 6F) -CH = CFCF 2 O-Ph-Ph-Ph (2F, 6F) -CN
C 2 H 5 -Ph (2F, 6F) -Ph-CH = CFCF 2 O-Ph-Ph-Ph (2F) -CN
CH 3 -CH = CH-C 2 H 4 -Ph-Ph-CH = CFCF 2 O-Ph-Ph-Ph (2F) -F
CH 2 = CH-Cy-Cy-CH = CFCF 2 O-Ph-Cy-Ph (2F) -OCF 3
C 3 H 7 -Cy-Cy-CH = CFCF 2 O-Ph-Cy-Ph (2F, 6F) -F
C 3 H 7 -Cy-Cy-CH = CFCF 2 O-Ph-Cy-Ph (2F, 3F) -OC 2 H 5
C 2 H 5 O-Cy-Cy-CH = CFCF 2 O-Ph-Ph-Ph (2F) -OCF 3
C 3 H 7 -Cy-Cy-CH = CFCF 2 O-Ph-Ph-Ph (2F, 6F) -F
C 3 H 7 -Cy-Cy-CH = CFCF 2 O-Ph-Ph (2F) -Ph (2F, 6F) -CN
C 3 H 7 -Cy-Cy-CH = CFCF 2 O-Ph-Ph-Ph (2F, 3F) -OC 2 H 5
C 3 H 7 -Cy-Ph-CH = CFCF 2 O-Ph-Ph-Ph (2F) -OCF 3
C 3 H 7 -Cy-Ph (2F, 6F) -CH = CFCF 2 O-Ph-Ph-Ph (2F, 6F) -F
C 3 H 7 -Cy-Ph (2F) -CH = CFCF 2 O-Ph-Ph (2F, 6F) -Ph (2F, 6F) -CN
C 2 H 5 -Cy-Ph (2F, 6F) -CH = CFCF 2 O-Ph-Ph-Ph (2F) -CN
C 3 H 7 -Cy-Ph-CH = CFCF 2 O-Ph-Ph-Ph (2F, 6F) -F
CH 2 = CH-Cy-Ph-CH = CFCF 2 O-Ph-Ph-Ph (2F) -F
Claims (7)
R1−(A1)a−Z1−(A2)b−Z2−(A3)c−Z3−A4−CH=CFCF2O−A5−Z4−(A6)d−Z5−(A7)e−R2 (1)
式(1)中の記号は、以下の意味を示す。
R1、R2:相互に独立して、水素原子、ハロゲン原子、−CN、−NCS、−SF5または炭素数1〜18の1価の脂肪族炭化水素基であり、基中の1つ以上の−CH2 −は、エーテル性酸素原子、チオエーテル性硫黄原子で置換されていてもよく、基中の任意の水素原子はフッ素原子で置換されていてもよい。
A1、A2、A3、A4、A5、A6、A7:相互に独立して、トランス−1,4−シクロへキシレン基、1,4−シクロヘキセニレン基、1,3−シクロブチレン基、1,2−シクロプロピレン基、ナフタレン−2,6−ジイル基、1,2,3,4−テトラヒドロナフタレン−2,6−ジイル基、デカヒドロナフタレン−2,6−ジイル基、または1,4−フェニレン基。該基中の1つ以上の水素原子はハロゲン原子で置換されていてもよく、該基中に存在する1つまたは2つの=CH−基は窒素原子で置換されていてもよく、1つまたは2つの−CH2−基はエーテル性酸素原子またはチオエーテル性硫黄原子で置換されていてもよい。
Z1、Z2、Z3、Z4、Z5:相互に独立して、単結合、炭素数1〜4の2価の脂肪族炭化水素基であり、基中の1つ以上の−CH2 −は、エーテル性酸素原子、チオエーテル性硫黄原子で置換されていてもよく、基中の任意の水素原子はフッ素原子で置換されていてもよい。
a、b、c、d、e:相互に独立して0または1。ただし、0≦a+b+c+d+e≦3。 A liquid crystal compound represented by the following formula (1).
R 1 - (A 1) a -Z 1 - (A 2) b -Z 2 - (A 3) c -Z 3 -A 4 -CH = CFCF 2 O-A 5 -Z 4 - (A 6) d -Z 5 - (A 7) e -R 2 (1)
The symbol in Formula (1) shows the following meanings.
R 1 and R 2 are each independently a hydrogen atom, a halogen atom, —CN, —NCS, —SF 5 or a monovalent aliphatic hydrocarbon group having 1 to 18 carbon atoms, and one of the groups more -CH 2 - may etheric oxygen atom may be substituted by thioether sulfur atoms, any hydrogen atom in the group may be substituted with a fluorine atom.
A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 : independently of each other, trans-1,4-cyclohexylene group, 1,4-cyclohexenylene group, 1, 3 -Cyclobutylene group, 1,2-cyclopropylene group, naphthalene-2,6-diyl group, 1,2,3,4-tetrahydronaphthalene-2,6-diyl group, decahydronaphthalene-2,6-diyl group Or 1,4-phenylene group. One or more hydrogen atoms in the group may be substituted with a halogen atom, and one or two ═CH— groups present in the group may be substituted with a nitrogen atom. Two —CH 2 — groups may be substituted with an etheric oxygen atom or a thioetheric sulfur atom.
Z 1 , Z 2 , Z 3 , Z 4 , Z 5 : each independently a single bond, a divalent aliphatic hydrocarbon group having 1 to 4 carbon atoms, and one or more —CH in the group 2 - is an etheric oxygen atom may be substituted by thioether sulfur atoms, any hydrogen atom in the group may be substituted with a fluorine atom.
a, b, c, d, e: 0 or 1 independently of each other. However, 0 ≦ a + b + c + d + e ≦ 3.
R11−(A11)a−Z11−(A21)b−Z21−(A31)c−Z31−A41−CH=CFCF2O−A51−Z41−(A61)d−Z51−(A71)e−R21 (1−1)
式中の記号は、以下の意味を示す。
R11、R21:相互に独立して、水素原子、フッ素原子、−SF5、または炭素数1〜18のアルキル基、または炭素数2〜18のアルケニル基。該基中の1つ以上の−CH2−はエーテル性酸素原子またはチオエーテル性硫黄原子に置換されていてもよく、基中の1つ以上の水素原子はフッ素原子で置換されていてもよい。
A11、A21、A31、A41、A51、A61、A71:相互に独立して、トランス−1,4−シクロへキシレン基、または1,4−フェニレン基。該基中の1つ以上の水素原子はハロゲン原子で置換されていてもよく、基中に存在する1つまたは2つの=CH−基は窒素原子で置換されていてもよく、1つまたは2つの−CH2−基はエーテル性酸素原子またはエーテル性硫黄原子で置換されていてもよい。
Z11、Z21、Z31、Z41、Z51:相互に独立して、単結合、炭素数1〜4のアルキレン基であり、基中の1つ以上の−CH2−はエーテル性酸素原子に置換されていてもよく、また基中の1つ以上の水素原子はフッ素原子で置換されていてもよい。
a、b、c、d、eは式(1)と同じ意味である。 The liquid crystal compound according to claim 1 represented by the following formula (1-1).
R 11 - (A 11) a -Z 11 - (A 21) b -Z 21 - (A 31) c -Z 31 -A 41 -CH = CFCF 2 O-A 51 -Z 41 - (A 61) d -Z 51 - (A 71) e -R 21 (1-1)
The symbols in the formula have the following meanings.
R 11 and R 21 are each independently a hydrogen atom, a fluorine atom, —SF 5 , an alkyl group having 1 to 18 carbon atoms, or an alkenyl group having 2 to 18 carbon atoms. One or more —CH 2 — in the group may be substituted with an etheric oxygen atom or a thioetheric sulfur atom, and one or more hydrogen atoms in the group may be substituted with a fluorine atom.
A 11 , A 21 , A 31 , A 41 , A 51 , A 61 , A 71 : Independently of each other, a trans-1,4-cyclohexylene group or a 1,4-phenylene group. One or more hydrogen atoms in the group may be substituted with a halogen atom, and one or two ═CH— groups present in the group may be substituted with a nitrogen atom. One —CH 2 — group may be substituted with an etheric oxygen atom or an etheric sulfur atom.
Z 11 , Z 21 , Z 31 , Z 41 , Z 51 are each independently a single bond or an alkylene group having 1 to 4 carbon atoms, and one or more —CH 2 — in the group is an etheric oxygen An atom may be substituted, and one or more hydrogen atoms in the group may be substituted with a fluorine atom.
a, b, c, d and e have the same meaning as in formula (1).
R12−(A12)a−Z12−(A22)b−Z22−(A32)c−Z32−A42−CH=CFCF2O−A52−Z42−(A62)d−Z52−(A72)e−R22 (1−2)
式中の記号は、以下の意味を示す。
R12:水素原子または炭素数1〜10のアルキル基。該基中の1つ以上の−CH2−はエーテル性酸素原子で置換されていてもよく、また基中の1つ以上の水素原子はフッ素で置換されていてもよい。
R22:水素原子、フッ素原子、−SF5、または炭素数1〜18のアルキル基。該基中の1つ以上の−CH2−はエーテル性酸素原子で置換されていてもよく、また基中の1つ以上の水素原子はフッ素原子で置換されていてもよい。
A12、A22、A32、A42、A52、A62、A72:相互に独立して、トランス−1,4−シクロへキシレン基、1,4−フェニレン基または1つもしくは2つのフッ素原子で置換された1,4−フェニレン基。
Z12、Z22、Z32、Z42、Z52:相互に独立して、単結合、炭素数1〜4のアルキレン基。
a、b、c、d、eは式(1)と同じ意味である。 The liquid crystal compound according to claim 1 represented by the following formula (1-2).
R 12 - (A 12) a -Z 12 - (A 22) b -Z 22 - (A 32) c -Z 32 -A 42 -CH = CFCF 2 O-A 52 -Z 42 - (A 62) d -Z 52 - (A 72) e -R 22 (1-2)
The symbols in the formula have the following meanings.
R 12 : a hydrogen atom or an alkyl group having 1 to 10 carbon atoms. One or more —CH 2 — in the group may be substituted with an etheric oxygen atom, and one or more hydrogen atoms in the group may be substituted with fluorine.
R 22 : a hydrogen atom, a fluorine atom, —SF 5 , or an alkyl group having 1 to 18 carbon atoms. One or more —CH 2 — in the group may be substituted with an etheric oxygen atom, and one or more hydrogen atoms in the group may be substituted with a fluorine atom.
A 12 , A 22 , A 32 , A 42 , A 52 , A 62 , A 72 : independently of each other, trans-1,4-cyclohexylene group, 1,4-phenylene group, or one or two of them 1,4-phenylene group substituted by a fluorine atom.
Z 12 , Z 22 , Z 32 , Z 42 , Z 52 : each independently a single bond, an alkylene group having 1 to 4 carbon atoms.
a, b, c, d and e have the same meaning as in formula (1).
工程(1):下記式(2)で表される化合物をハロゲン化し下記式(3)で表される化合物を得る工程。
R1−(A1)a−Z1−(A2)b−Z2−(A3)c−Z3−A4−CH2CF=CF2 (2)
R1−(A1)a−Z1−(A2)b−Z2−(A3)c−Z3−A4−CH2CFX1CF2X2 (3)
工程(2):前記式(3)で表される化合物に対し、下記式(4)で表される化合物を反応させ、前記式(1)で表される液晶化合物を得る工程。
Y1O−A5−Z4−(A6)d−Z5−(A7)e−R2 (4)
各式中、
R1、R2、A1〜A7、Z1〜Z5およびa〜eは、請求項1における式(1)の定義と同様である。
X1およびX2:ハロゲン原子。
Y1:水素原子、アルカリ金属原子、またはアルカリ土類金属原子。 The manufacturing method of the liquid-crystal compound of Claim 1 including the following process (1) and process (2).
Step (1): A step of halogenating a compound represented by the following formula (2) to obtain a compound represented by the following formula (3).
R 1- (A 1 ) a -Z 1- (A 2 ) b -Z 2- (A 3 ) c -Z 3 -A 4 -CH 2 CF = CF 2 (2)
R 1 - (A 1) a -Z 1 - (A 2) b -Z 2 - (A 3) c -Z 3 -A 4 -CH 2 CFX 1 CF 2 X 2 (3)
Step (2): A step of obtaining a liquid crystal compound represented by the formula (1) by reacting a compound represented by the following formula (4) with the compound represented by the formula (3).
Y 1 O—A 5 —Z 4 — (A 6 ) d —Z 5 — (A 7 ) e —R 2 (4)
In each formula,
R 1 , R 2 , A 1 to A 7 , Z 1 to Z 5, and a to e are the same as defined in the formula (1) in claim 1.
X 1 and X 2 : a halogen atom.
Y 1 : a hydrogen atom, an alkali metal atom, or an alkaline earth metal atom.
R1−(A1)a−Z1−(A2)b−Z2−(A3)c−Z3−A4−CH2CFX1CF2X2 (3)
式中、
R1:水素原子、ハロゲン原子、−CN、−NCS、−SF5または炭素数1〜18の1価の脂肪族炭化水素基であり、基中の1つ以上の−CH2 −は、エーテル性酸素原子、チオエーテル性硫黄原子で置換されていてもよく、基中の任意の水素原子はフッ素原子で置換されていてもよい。
A1〜A4:相互に独立して、トランス−1,4−シクロへキシレン基、1,4−シクロヘキセニレン基、1,3−シクロブチレン基、1,2−シクロプロピレン基、ナフタレン−2,6−ジイル基、1,2,3,4−テトラヒドロナフタレン−2,6−ジイル基、デカヒドロナフタレン−2,6−ジイル基、または1,4−フェニレン基。該基中の1つ以上の水素原子はハロゲン原子で置換されていてもよく、該基中に存在する1つまたは2つの=CH−基は窒素原子で置換されていてもよく、1つまたは2つの−CH2−基はエーテル性酸素原子またはチオエーテル性硫黄原子で置換されていてもよい。
Z1〜Z3:相互に独立して、単結合、炭素数1〜4の2価の脂肪族炭化水素基であり、基中の1つ以上の−CH2 −は、エーテル性酸素原子、チオエーテル性硫黄原子で置換されていてもよく、基中の任意の水素原子はフッ素原子で置換されていてもよい。
a、b、c、d、e:相互に独立して0または1。ただし、0≦a+b+c+d+e≦3。
X1およびX2:ハロゲン原子。 A compound represented by the following formula (3).
R 1 - (A 1) a -Z 1 - (A 2) b -Z 2 - (A 3) c -Z 3 -A 4 -CH 2 CFX 1 CF 2 X 2 (3)
Where
R 1 is a hydrogen atom, a halogen atom, —CN, —NCS, —SF 5 or a monovalent aliphatic hydrocarbon group having 1 to 18 carbon atoms, and one or more —CH 2 — in the group is an ether An oxygen atom or a thioetheric sulfur atom, and any hydrogen atom in the group may be substituted with a fluorine atom.
A 1 to A 4 : independently of each other, trans-1,4-cyclohexylene group, 1,4-cyclohexenylene group, 1,3-cyclobutylene group, 1,2-cyclopropylene group, naphthalene- 2,6-diyl group, 1,2,3,4-tetrahydronaphthalene-2,6-diyl group, decahydronaphthalene-2,6-diyl group, or 1,4-phenylene group. One or more hydrogen atoms in the group may be substituted with a halogen atom, and one or two ═CH— groups present in the group may be substituted with a nitrogen atom. Two —CH 2 — groups may be substituted with an etheric oxygen atom or a thioetheric sulfur atom.
Z 1 to Z 3 are each independently a single bond, a divalent aliphatic hydrocarbon group having 1 to 4 carbon atoms, and one or more —CH 2 — in the group is an etheric oxygen atom, It may be substituted with a thioetheric sulfur atom, and any hydrogen atom in the group may be substituted with a fluorine atom.
a, b, c, d, e: 0 or 1 independently of each other. However, 0 ≦ a + b + c + d + e ≦ 3.
X 1 and X 2 : a halogen atom.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011051837A JP2011207871A (en) | 2010-03-11 | 2011-03-09 | Liquid crystal compound, method for producing the same, liquid crystal composition and liquid crystal electrooptical element |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010054080 | 2010-03-11 | ||
JP2010054080 | 2010-03-11 | ||
JP2011051837A JP2011207871A (en) | 2010-03-11 | 2011-03-09 | Liquid crystal compound, method for producing the same, liquid crystal composition and liquid crystal electrooptical element |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2011207871A true JP2011207871A (en) | 2011-10-20 |
Family
ID=44939313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011051837A Pending JP2011207871A (en) | 2010-03-11 | 2011-03-09 | Liquid crystal compound, method for producing the same, liquid crystal composition and liquid crystal electrooptical element |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2011207871A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013001725A (en) * | 2011-06-13 | 2013-01-07 | Jnc Corp | Compound, liquid crystal composition and liquid crystal display element |
JP6308414B1 (en) * | 2016-10-25 | 2018-04-11 | Dic株式会社 | Liquid crystal composition and liquid crystal display element |
WO2018079218A1 (en) * | 2016-10-25 | 2018-05-03 | Dic株式会社 | Liquid crystal composition and liquid crystal display element |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5046610A (en) * | 1973-08-21 | 1975-04-25 | ||
JPS6317858A (en) * | 1986-07-11 | 1988-01-25 | Sagami Chem Res Center | Production of fluorine-containing cyclic compound |
JPH0753506A (en) * | 1993-08-02 | 1995-02-28 | Korea Res Inst Chem Technol | New fluoroalkyl derivative and its production |
JP2002053513A (en) * | 2000-08-10 | 2002-02-19 | Chisso Corp | Difluoromethyl ether derivative and method for producing the same |
JP2002293764A (en) * | 2001-01-26 | 2002-10-09 | Takeda Chem Ind Ltd | Aminoethanol derivative |
WO2006106655A1 (en) * | 2005-03-31 | 2006-10-12 | Daikin Industries, Ltd. | Electrolyte solution |
-
2011
- 2011-03-09 JP JP2011051837A patent/JP2011207871A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5046610A (en) * | 1973-08-21 | 1975-04-25 | ||
JPS6317858A (en) * | 1986-07-11 | 1988-01-25 | Sagami Chem Res Center | Production of fluorine-containing cyclic compound |
JPH0753506A (en) * | 1993-08-02 | 1995-02-28 | Korea Res Inst Chem Technol | New fluoroalkyl derivative and its production |
JP2002053513A (en) * | 2000-08-10 | 2002-02-19 | Chisso Corp | Difluoromethyl ether derivative and method for producing the same |
JP2002293764A (en) * | 2001-01-26 | 2002-10-09 | Takeda Chem Ind Ltd | Aminoethanol derivative |
WO2006106655A1 (en) * | 2005-03-31 | 2006-10-12 | Daikin Industries, Ltd. | Electrolyte solution |
Non-Patent Citations (5)
Title |
---|
JPN6014051814; Valentine G. et al.: Journal of Fluorine Chemistry Vol.125, 2004, p.1339-1345 * |
JPN6014051815; B. Ameduri et al.: Journal of Fluorine Chemistry Vol.93, 1999, p.139-144 * |
JPN6014051816; J. D. Park et al.: The Journal of Organic Chemistry Vol.26, Issue6, 1961, p.2089-2095 * |
JPN6014051817; 化学便覧 応用化学編 第6版 , 2003, 第1010-1016頁, 丸善株式会社 * |
JPN7014003519; Dmitri V. et al.: Synlett No.3, 2001, p.379-381 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013001725A (en) * | 2011-06-13 | 2013-01-07 | Jnc Corp | Compound, liquid crystal composition and liquid crystal display element |
JP6308414B1 (en) * | 2016-10-25 | 2018-04-11 | Dic株式会社 | Liquid crystal composition and liquid crystal display element |
WO2018079218A1 (en) * | 2016-10-25 | 2018-05-03 | Dic株式会社 | Liquid crystal composition and liquid crystal display element |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI631207B (en) | Liquid crystal composition and usage thereof and liquid crystal display element | |
TW201833311A (en) | Liquid-crystalline medium and liquid-crystal display comprising the same | |
JP5575362B2 (en) | Liquid crystal media | |
TWI393767B (en) | Liquid crystal composition | |
KR20080017466A (en) | Liquid-crystalline medium and liquid crystal display with 1,2-difluoroethene compounds | |
TW201928024A (en) | Liquid-crystalline medium and liquid-crystal display comprising the same | |
CN105295954A (en) | Liquid-crystal medium | |
TWI413676B (en) | Liquid-crystalline medium | |
CN116368132A (en) | 4, 6-difluorodibenzothiophene derivatives and liquid crystal media containing the same | |
TWI386482B (en) | Liquid crystal composition | |
US8273420B2 (en) | Liquid crystal compound and process for production thereof, liquid crystal composition, and liquid crystal electrooptical element | |
JP2014025025A (en) | Liquid crystal composition including a liquid crystal compound and a triplet quencher | |
JP5022895B2 (en) | Liquid crystal media | |
JP2011207871A (en) | Liquid crystal compound, method for producing the same, liquid crystal composition and liquid crystal electrooptical element | |
JP2013112621A (en) | Liquid crystal compound, method for producing the same, liquid crystal composition, and liquid crystal electrooptical element | |
JP4306190B2 (en) | Liquid crystal composition | |
JP5763937B2 (en) | Liquid crystal compound, method for producing the same, liquid crystal composition, and liquid crystal electro-optical element | |
WO2013031603A1 (en) | Liquid-crystal compound, manufacturing method therefor, liquid-crystal composition, and liquid-crystal electro-optical element | |
WO2014125924A1 (en) | Novel compound having cyclic structure with negative dielectric anisotropy, method for producing said compound, liquid crystal composition, and liquid crystal electrooptical element | |
KR20110114536A (en) | Fluorine-containing liquid crystal compound, liquid crystal composition, and liquid crystal electro-optic element | |
JP2013112620A (en) | Liquid crystal compound, method for producing the same, liquid crystal composition, and liquid crystal electrooptical element | |
JP5680381B2 (en) | Liquid crystal compound, method for producing the same, liquid crystal composition, and liquid crystal electro-optical element | |
JP5763938B2 (en) | Liquid crystal compound, method for producing the same, liquid crystal composition, and liquid crystal electro-optical element | |
JPWO2014157551A1 (en) | Compound, method for producing the same, liquid crystal composition, and liquid crystal electro-optical element | |
JP2012126709A (en) | Liquid crystal compound, liquid crystal composition, and liquid crystal element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140107 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20141204 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20141209 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150407 |